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Aberrant activation of macrophages during inflammation results in oxidative 
burst release of reactive oxygen and reactive nitrogen species (ROS/RNS) which 
are widely accepted to participate in pathogenesis of cancer, cardiovascular 
disease, atherosclerosis, hypertension, ischemia/reperfusion injury, diabetes 
mellitus, neurodegenerative diseases (Alzheimer’s disease and Parkinson’s 
disease), rheumatoid arthritis, and ageing. It is demonstrated here that Didox 
(3,4-Dihydroxybenzohydroxamic acid) possesses antioxidative and anti-
inflammatory properties that can protect against inflammation and oxidative 
stress induced by lipopolysaccharide (LPS) and aryl hydrocarbon receptor (AHR) 
ligands (PCB126, E804, and IO) in Raw 264.7 murine macrophages. In brief, it is 
demonstrated here that Didox inhibits LPS-induced oxidative stress, ROS/RNS 
generations, IL-6 production, NO production, phagocytic activity, and NF-κB 
nuclear translocation in Raw 264.7 murine macrophages. Furthermore, Didox 
downregulated ROS production, cytochrome P450 1A1 (CYP1A1), and AHR 
nuclear translocation induced by PCB126, E804, and IO in Raw 264.7 murine 
macrophages. These data suggest that oxidative stress regulatory effects of 
Didox may be useful in managing inflammatory diseases conditions initiated by 
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CHAPTER 1: LITERATURE REVIEW 
 
1.1 Inflammation and Oxidative stress 
Inflammation is a complex stereotypical response of the damage to the body 
cells and vascularized tissues. The inflammatory response is phylogenetically 
and ontogenetically the oldest defense mechanism that is controlled by 
cytokines, products of the plasma enzyme systems, lipid mediators released from 
different cells, and by vasoactive mediators released from mast cells, basophils, 
platelets and macrophages (Ross et al., 2002). Inflammation is the complex 
immunological response of vascular tissues to exogenous or endogenous 
harmful stimuli, such as pathogens, damaged cells, or irritants. It is a protective 
attempt by the immune system to remove the injurious agents as well as initiate 
the healing process for tissues.  
 
When inflammation is lacking, wounds and infections persist and never heal 
while progressive destruction of body tissue continue to compromise the survival 
of the organism. However, aberrant inflammation can also lead to a host of 
diseases, such as atherosclerosis, cancer, respiratory syndromes, multiple organ 
dysfunction and rheumatoid arthritis (Fig 1.1, below). It is for that reason that 
inflammation is normally closely regulated by the body. Inflammation can be 
classified as either acute or chronic according to duration of response (Khansari 
et al., 2009).   
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Acute inflammation is the relatively shorter initial response of the body to harmful 
stimuli and is achieved by the increased movement of plasma and leukocytes 
from the blood into the site of injury or infection. It is a short-term process, usually 
appearing in a few minutes or hours and ceasing once the injurious stimulus has 
been removed. It is characterized by five cardinal signs: rubor (redness), calor 
(increased heat), tumor (swelling), dolor (pain), and functio laesa (loss of 
function). Recruitment of leukoctyes and production of various mediators trigger a 
cascade of biochemical events which propagates and matures the inflammatory 
response, involving the local vascular system, the immune system, and various 
cells within the injured tissue. Prolonged inflammation, known as chronic 
inflammation, leads to a progressive shift in the type of cells which are present at 
the site of inflammation and is characterised by a lengthy simultaneous 
destruction and healing of the tissue from the inflammatory process (Ferrero-
Miliani et al., 2007). 
Chronic inflammation is a pathological condition characterized by continued 
active inflammation response and tissue destruction. Many of the immune cells 
including macrophages, neutrophils and eosinophils are involved directly or by 
production of inflammatory cytokines in pathology of chronic inflammation. 
Chronic inflammation can be a major cause of cancers and neurodenegerative 
diseases. Moreover, many studies suggest that chronic inflammation could play a 
serious role in wide variety of age-related diseases including diabetes, 
cardiovascular and autoimmune diseases. Inflammatory processes induce 
oxidative stress and reduce cellular antioxidant capacity (Khansari et al., 2009). 
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Figure 1.1 Consequences of aberrant inflammation and oxidative stress in 
physiology. Oxidative stress and chronic inflammation can lead to a wide variety 
disease conditions in multiple organs, rendering the usually protective immune reaction 
a liability rather than an asset. 
 
 
Overproduced free radicals react with cell membrane fatty acids and proteins 
impairing their function permanently. In addition, free radicals can lead to 
mutation and DNA damage that can be a predisposing factor for cancer and age-




The generation of reactive oxygen species (ROS) and other free radicals during 
metabolism is a necessary and normal process that ideally is compensated for by 
an elaborate endogenous antioxidant system. However, due to many 
environmental, lifestyle, and pathological situations, excess radicals can 
accumulate, resulting in oxidative stress (Figure 2). Oxidative stress has been 
related to cardiovascular disease, cancer, and other chronic diseases that 
account for a major portion of deaths today. Antioxidants are compounds that 
hinder the oxidative processes and thereby delay or prevent oxidative stress 
(Khansari et al., 2009). 
 
1.1 (a) Reactive Oxygen intermediates and oxidative stress 
Reactive oxygen species (ROS) are a cluster of highly unstable compounds that 
are generated during inflammation and normal cellular metabolism via 
incomplete reduction of molecular oxygen. They consist of molecules with 
unpaired electrons such as superoxide anions (O2
− ) and hydroxyl radical ( OH), 
and molecules that have oxidizing propensity but do not possess free electrons, 
for example hydrogen peroxide (H2O2) and hypochlorous acid (HOCl) (Abid et al., 
2005) . These species are involved in the regulation of fundamental cellular 
activities such as cell growth and differentiation (Dor and Porat, 2001; D'Angio 
and Maniscalco, 2002, Hopf et al., 2005 , and Veal et al., 2007). However, their 
overproduction and/or the presence of impaired antioxidant ability results in 
oxidative stress which can induce and propagate significant injury (Fig 1.2). 
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Likewise, reactive nitrogen species (RNS), the by-products of nitric oxide (NO) 
metabolism, play an important role in maintaining various physiological functions 
at basal levels, and contribute to several pathological processes at high levels. 
Examples of RNS include nitrite (NO2
-), nitrate (NO3
−) and peroxynitrite (ONOO−)  
 
 
Figure 1.2: Antioxidants and reactive oxygen species (ROS) exist in physiological 
balance and are required for normal cellular function. Excessive generation of free 
radicals generation of free radicals such as OH•, NO, O2
•, H2O2 and deficiency of 
antioxidants can lead to oxidative stress whereas the reverse leads to ROS deficiency.  
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As these reactive oxygen and nitrogen species are deemed as second 
messengers, it is important to note that they should have four basic 
characteristics that allow regulation. (1) They are either enzymatically generated 
or regulated by channels and pumps (2) They are enzymatically degraded. (3) 
Their concentration rises and falls within a short period, and (4) They can be 
specific in action (Boueiz and Hassoun, 2009).  
 
1.1 (b) Reactive oxygen species 
As divalent reduction of O2 to form H2O2 is spin restricted, one electron reduction 
is favored and O2
− is readily formed. Therefore, the major source of H2O2 in cells 
arises from the dismutation of O2
−. At physiological pH, non-enzymatic 
dismutation is rapid, but dismutation is markedly accelerated by the superoxide 
dismutases (SOD) to near the limit of diffusion. H2O2 can diffuse readily through 
membranes, probably through the same channels as water. H2O2 is not a radical 
and does not spontaneously react with carbon-centered molecules or thiols. It 
does, however, react rapidly with thiolates (–S−) and transition metals. Hydroxyl 
radical (OH•) can be generated when H2O2 collides with a reduced transition 
metal, such as ferrous iron (Fe2++H2O2→Fe
3++OH−+OH•) in a Fenton reaction. 
The distribution of transition metals in the cell is generally well regulated and so-
called free transition metals are associated with pathology rather than signaling. 
The hydroxyl radical is so reactive that it will generally abstract a hydrogen from 
the closest molecule, producing water and another radical. As damage to the 
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molecule would probably ensue, it seems rather unlikely that OH• could act as a 
second messenger. On the contrary, O2
•− and H2O2 have all four of the 
characteristics of second messengers as defined above, i.e. they are generated 
enzymatically, degraded by SOD or catalase and glutathione peroxidases, are 
present at very low concentrations but can transiently be elevated to measurable 
amounts and both react only at specific sites, such as metals and thiolates 
(Khansari et al., 2009). 
 
1.1 (c) Reactive nitrogen species 
The NO molecule itself has little chemical reactivity with organic molecules and 
primarily binds to metals as in the regulatory site of guanylate cyclase and in 
hemoglobin. In fact, guanylate cyclase has been shown to require NO binding to 
its regulatory site in order to be active. Moreover, NO interacts with O2
− to form 
ONOO− , a reaction that is extremely fast (6.7×109 mol−1 s−1) and is determined 
by the diffusion rate of NO, the relative amount of each radical, and their ability to 
react with oxyHb for NO and SOD for O2
−. Thus, this reaction can only occur in 
localized areas close to the source of O2
− release (Wink and Mitchell, 1998). The 
peroxynitrite molecule is not itself highly reactive; however, its acid form, 
peroxynitrous acid (ONOOH) is very unstable and reactive, having properties 
similar to OH• and nitrogen dioxide (NO2). The formation of peroxynitrous acid is 
thought to be the mechanism through which NO production can lead to toxicity 
and the predominant mechanism of O2
−-mediated toxicity when Fenton chemistry 
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is not involved. It was widely assumed that ONOO− was destroyed through non-
enzymatic degradation until recent studies suggested that glutathione peroxidase 
could catalyze the reduction of ONOO− to NO2
− (Sies and Arteel, 2000). That an 
enzymatic mechanism appears to exist for its elimination is consistent with a role 
for ONOO− as a second messenger. Peroxynitrite can interact with the cysteine 
residues of proteins or glutathione, resulting in formation of S-nitrosothiols and 
providing both a mechanism for regulation of thiol-dependent enzymatic activities 
and a source of bioavailable NO that can be exchanged between thiols. 
Peroxynitrite also modifies tyrosine residues, producing 3-nitrotyrosine (3NT). 
While thought to be an irreversible process associated with injury, tyrosine 
nitration may have a signaling role and be enzymatically reversed. Perhaps like 
H2O2, ONOO
− participates in signaling processes at low concentrations but, at 
greater concentrations, produces toxicity (Boueiz and Hassoun, 2009). 
 
1.1 (d) Antioxidant defense and redox signaling 
The production of reactive oxygen and nitrogen species is a steady-state event in 
respiring cells, and uncontrolled production of these reactive species is the 
primary cause of some major degenerative conditions. Cellular defense, targeted 
against these transient but damaging species, can be grouped under several 
mechanisms, and collectively they operate to terminate free radical reactions or 
remove reactive species and their secondary products. Since oxygen and 
nitrogen atoms of reactive oxygen intermediates (ROI) contain unpaired 
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electrons in their outer electron shells, they can react with other molecules to 
restore their electron pairing. These could lead to damaging of biological 
molecules such as nucleic acids, proteins, and lipids. To minimize heavy metal–
induced catalysis of the Fenton and Haber-Weiss reactions that generate the 
most reactive hydroxyl radical, expression of several specific metal-binding 
proteins such as haptoglobin, ceruloplasmin, ferritin, transferrin, lactoferrin, and 
albumin, ensures that these metals remain cryptic, thereby serving as a key 
preventive measure in the overall free radical defense system. Antioxidant 
enzymes, most of which are highly dependent upon exogenous co-factors for 
their activity, can dismutate superoxide anion (superoxide dismutase) directly into 
hydrogen peroxide which in turn can be removed by catalase or several forms of 
glutathione peroxidase.  
Finally, direct quenching of radicals can be achieved by a series of endogenous 
and exogenous antioxidants. Functioning as scavengers, these molecules donate 
electrons, and themselves become free radicals that can either initiate chain 
reactions or conversely, be regenerated. It is now known that active repair 
pathways exist in which endogenous antioxidants such as glutathione, ubiquinol 
and NADH/NADPH, are obligatory in the recycling pathways via redox reactions. 
It has long been known that control of the intracellular redox environment is vital 
for proper cellular function. To protect themselves from the constant oxidative 
challenge, cells have developed defense mechanisms that insure the proper 
balance between the prooxidant and antioxidant molecules. In addition to the 
enzymes that remove ROS, such as SOD, catalase and glutathione peroxidase, 
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glutathione (GSH/GSSG) and thioredoxin (Trx) systems are key players in the 
maintenance of the redox status of the cells, defined as the ratio of the 
concentration of oxidizing equivalents to that of reducing equivalents. Members 
of the Trx family have a conserved catalytic site with two cysteine residues that 
undergo reversible oxidation to form a disulfide bridge through the transferring of 
reducing equivalent to a disulfide substrate. The Trx then reverts to the reduced 
form through the action of Trx reductase, an NADPH flavoprotein. Similarly, the 
GSH/GSSG ratio is controlled by glutathione reductase. Peroxiredoxins are 
another class of enzymes that can reduce H2O2 using thiols (Rhee et al., 1999), 
some using thioredoxin as a co-substrate and at least one using glutathione ( 
Chen et al., 2000). 
The antioxidant enzymes play a significant role in protection against cell injury. 
Nonetheless, these enzymes may also play an additional role in signaling by 
counterbalancing the production of ROS/RNS. Indeed, one may think of a role for 
glutathione peroxidase in decreasing H2O2 concentration as analogous to the 
role of phosphodiesterase in decreasing cAMP concentration. In other words, the 
antioxidant enzymes provide the turn-off component of redox signaling. The 
interplay between ROS signaling and inflammation involves a complex cellular 
network comprising vascular cells and inflammatory and immune cells. Among 
them, macrophages have a unique central role and mediator of co-ordinated 
cellular and intercellular inflammatory reactions. 
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1.1 (e) Oxidative stress and NF-κB signaling 
The nuclear factor associated κB (NF-κB) transcription factor plays a major role 
in coordinating innate and adaptative immunity, cellular proliferation, apoptosis 
and development. Since the discovery in 1991 that NF-κB may be activated by 
H2O2, several laboratories have put a considerable effort into dissecting the 
molecular mechanisms underlying this activation. Whereas early studies 
revealed an uncharacteristic mechanism of activation, leading to IκBα 
phosphorylation independently of IκB kinase (IKK), recent findings suggest that 
H2O2 activates NF-κB mainly through the classical IKK-dependent pathway. The 
molecular mechanisms leading to IKK activation are, however, cell-type specific 
and the description of  the effect of other ROS and RNS on NF-κB activation 
comes essential. Recent data also highlights the role of ROS in NF-κB activation 
by proinflammatory cytokines (TNF-α and IL-1β) and lipopolysaccharide (LPS), 
two major components of macrophages-mediated innate immunity (Gloire et al., 
2006). 
The transcription factor NF-κB is crucial in a series of cellular processes, such as 
inflammation, immunity, cell proliferation and apoptosis. It consists of homo- or 
heterodimers of a group of five proteins, namely NF-κB1 (p50 and its precursor 
p105), NF-κB2 (p52 and its precursor p100), p65/RelA, c-Rel and RelB. In the 
resting state, NF-κB is sequestered in the cytoplasm of the cell through its tight 
association with inhibitory proteins called IκBs, comprising IκBα, IκBβ, IκBγ, IκBε, 
Bcl-3, p100 and p105. Upon cell stimulation, IκB proteins are rapidly 
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phosphorylated and degraded by the proteasome, and the freed NF-κB 
translocates into the nucleus to regulate the expression of multiple target genes 
(Hayden and Ghosh, 2004).  
The classical NF-κB-activating pathway is induced by a variety of mediators, 
such as pro-inflammatory cytokines (TNFα, IL-1β) and LPS binding to Toll-like 
receptors (mainly TLR4). Although these NF-κB inducers signal through different 
receptors and adaptor proteins, they all converge to the activation of IκB-kinase 
(IKK) complex, which includes the scaffold protein NF-κB essential modulator 
(NEMO, also called IKKγ), IKKα and IKKβ kinases. Once activated by 
phosphorylation, the IKK complex phosphorylates IκBα on Ser32 and Ser36, 
which is subsequently ubiquitinated and degraded via the proteasome pathway. 
The freed NF-κB then translocates into the nucleus where it activates the 
transcription of target genes such as cytokines (eg. IL-6), chemokines, adhesion 
molecules, inflammatory enzymes (e.g. iNOS) and apoptosis mediators (Bonizzi 
and Karin, 2004).  
Beside this classical activation, a novel NEMO-independent NF-κB-activating 
pathway, important for secondary lymphoid organ development and homeostasis 
and adaptive immunity, was described. It is induced by B-cell activating factor 
(BAFF), lymphotoxin β (LTβ), CD40 ligand  and human T cell leukemia (HTLV) 
and Epstein-Barr (EBV) virus . The NEMO-independent NF-κB-activating 
pathway enhances NF-κB inducing kinase (NIK)- and IKKα-dependent 
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processing of p100 into p52, which binds DNA in association with its partners, 
like RelB. These stimuli also activate the classical pathway (Gloire et al., 2006).  
 
In 1991, Schreck et al. were the first to demonstrate that direct addition of H2O2 
to the culture medium of a subclone of Jurkat cells (Jurkat JR) could activate NF-
κB (Schreck et al., 1991). Since this discovery, several laboratories have put 
considerable efforts into dissecting the molecular mechanisms underlying this 
activation. The results that came out of these studies suggest that NF-κB 
activation by H2O2 is highly cell-type specific and involves quite different 
mechanisms, making the role of H2O2 in macrophage signaling a subject of great 
importance since they produce it in large amounts during inflammatory reactions. 
Although the vast majority of studies concerning oxidant-induced NF-κB 
activation have focussed on H2O2, other oxidants, like hypochlorous acid (HOCl) 
and singlet oxygen (-O2), have been shown to modulate NF-κB activation. On the 
other hand, some works have also highlighted NF-κB regulation by peroxinitrite 
which is a reactive nitrogen species (Gloire et al., 2006).  
 
To explain the diversity of inducers that activate NF-κB via the same IKK-
dependent pathway, a model has emerged suggesting that all NF-κB activators 
cause an oxidative stress that is mainly responsible for IKK activation and IκBα 
degradation. This model is based on several observations, including that most of 
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NF-κB-inducers trigger the formation of ROS (Los et al., 1995) and that several 
antioxidants can block NF-κB activation (Schreck et al., 1992). As a result of 
research in these areas, the effects of different antioxidants (NAC, PDTC and 
GSH) or over-expression of antioxidant enzymes (SOD) on NF-κB activation by 
TNFα and IL-1β or LPS has been well documented. It will therefore be very 
interesting to find out what effect ROS and RNS will have on activated 
macrophages in searching for agents that can modulate macrophage activity.  
 
1.2 Macrophages 
Macrophages are key players in inflammation and their wide tissue distribution 
makes them well suited to provide an immediate defense against foreign 
elements prior to leukocyte migration (Zhang et al., 2008). Macrophages have 
long been considered to be important immune effector cells. Élie Metchnikoff, 
who won the Nobel Prize 100 years ago for his description of phagocytosis, 
proposed that the key to immunity was to "stimulate the phagocytes" (Nathan, 
2008). Since this discovery, immunologists have been occupied with the concept 
of macrophages as immune effector cells and with understanding how these cells 
participate in host defense. Macrophages are present in virtually all tissues. They 
differentiate from circulating peripheral-blood mononuclear cells (PBMCs), which 
migrate into tissue in the steady state or in response to inflammation. These 
PBMCs develop from a common myeloid progenitor cell in the bone marrow that 
is the precursor of many different cell types, including neutrophils, eosinophils, 
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basophils, macrophages, dendritic cells (DCs) and mast cells. During monocyte 
development, myeloid progenitor cells (termed granulocyte/macrophage colony-
forming units) sequentially give rise to monoblasts, pro-monocytes and finally 
monocytes, which are released from the bone marrow into the bloodstream.  
 
 
Figure 1.3: Macrophages play a central in inflammation by interacting with other 
inflammatory cells. Macrophages interact with neutrophils (NФ), dendritic cells (DC), B 
cells and T cells (Th1/h2) to co-ordinate a successful immune attack in attempt to 
remove the injurious stimuli. During chronic inflammation, macrophages release a 
plethora of mediators which not only lead to direct tissue injury but also recruit far too 




Monocytes migrate from the blood into tissue to replenish long-lived tissue-
specific macrophages of the bone (osteoclasts), alveoli, central nervous system 
(microglial cells), connective tissue (histiocytes), gastrointestinal tract, liver 
(Kupffer cells), spleen and peritoneum.  
 
Macrophages play a pivotal role in innate and adaptive immunity by interacting 
with other immunological and non-immunological cells to insure success of the 
inflammatory process and clearance of invaders. As such, they play a central role 
by interacting with cells such as neutrophils, dendritic cells, T cells, B cells, 
Natural killer cells and fibroblasts (Fig 1.3).  Concerning macrophage activation 
and phagocytosis, large volumes of macrophage research have unraveled the 
induction of cytokines such as IL-1β, IL-6, IL-10, TNF-α and transforming growth 
factor (TGF); chemokines such as monocyte chemoattractant protein-1 (MCP-1) 
and macrophage inflammatory protein-2 (MIP-2); the reactive oxygen species 
(ROS), reactive nitrogen species (RNS) and nitric oxide (NO)-generated mainly 
through iNOS.  
 
During microbial contact, many parallel signaling pathways are simultaneously 
activated that together define the phagocyte response and regulate 
internalization of microbes by macrophages.  Phagocytosis is a complex system 
with special emphasis on four sources of that complexity. First, many different 
receptors recognize microbes, and phagocytosis is usually mediated 
simultaneously by multiple receptors. Second, different microbe-recognition 
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receptors induce different signaling pathways, and these signals interact 
cooperatively (and sometimes destructively) to mediate ultimate responses to 
particles. Third, microbe recognition is coupled (either directly through phagocytic 
receptors or indirectly through co-receptors) to inflammatory responses that in 
turn affect the efficiency of particle internalization by the phagocyte or 
neighboring phagocytes. Fourth, many pathogenic microbes actively attempt to 
regulate the mechanisms of phagocytosis to evade destruction. In this review we 
have focused our discussion specifically on phagocytosis of microbes. 
Phagocytosis also is required for normal clearance of apoptotic cells, a process 
in which many of the same levels of complexity apply (Underhill and Ozinsky, 
2002). 
 
Particle internalization by macrophages is accompanied by activation of many 
signaling pathways that together orchestrate rearrangement of the actin 
cytoskeleton, extension of the plasma membrane, and engulfment. Dozens of 
signaling molecules including actin binding proteins, membrane traffic regulators, 
ion channels, kinases, and lipases are activated during phagocytosis of complex 
particles (such as opsonized bacteria) and may contribute to efficient 
internalization. Linking these proteins in a model of phagocytosis is a challenge, 
and identifying the key regulators is a task that requires a concerted effort. 
However, certain signaling molecules stand out both as participating in 
phagocytosis and as participating in many other signaling pathways. 
Phosphoinositide 3-kinase (PI 3-kinase), phospholipase C (PLC), Rho GTPases, 
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and PKC are integration points for regulating of phagocytosis. Furthermore, 
these molecules not only orchestrate the mechanics of particle ingestion, they 
also regulate inflammatory responses and microbial killing (Underhill and 
Ozinsky, 2002). 
 
PI 3-kinase catalyzes phosphorylation of PI(4,5)P2 to PI(3,4,5)P3, a phospholipid 
important in recruiting signaling molecules such as the kinase AKT/PKB to 
specific regions of membranes. Pharmacological inhibition of PI 3-kinase blocks 
phagocytosis of IgG- and complement-opsonized particles, unopsonized 
zymosan, and bacteria, although the requirement may not be absolute because 
the uptake of IgG-opsonized particles smaller than 3 microns across is less 
affected than the uptake of larger. Inhibition of PI 3-kinase blocks membrane 
extension and fusion behind the bound particle, perhaps due to a failure to insert 
new membrane at the site of particle internalization (Cox et al., 1999).  
 
In recent work using cells from knockout mice and microinjection of inhibitory 
antibodies, Vieira and colleagues have demonstrated that these stages of 
phagocytosis require class I PI 3-kinase, while a second type of PI 3-kinase, 
class II/VPS34, is required for phagosome maturation (Vieira et al., 2001). 
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Phosphoinositide-specific phospholipase C (PI-PLC) mediates cleavage of PI (4, 
5)P2 resulting in release of IP3 and DAG, second messengers that mobilize 
intracellular Ca++ stores and activate protein kinase C family members, 
respectively. PI-PLC is recruited to phagosomes containing IgG-opsonized 
particles, and inhibition of its activity blocks particle internalization. Like protein 
kinase C inhibitors, PLC inhibitors completely block the formation of actin 
filaments beneath the site of particle contact, suggesting that the main role of 
PLC in particle internalization is to activate protein kinase C (Botelho et al., 
2000). In addition to being required for the mechanical aspects of particle 
internalization, PI 3-kinase and PI-PLC also are implicated in pro-inflammatory 
signaling induced by particulate stimuli. Thus, PI 3-kinase is recruited to Toll-like 
receptors when cells are stimulated with heat-killed S. aureus, and activation of 
PI 3-kinase has been implicated in NF-κB-mediated cytokine production. 
Similarly, PI-PLC activity is required for microbe-induced pro-inflammatory 
signaling in macrophages primarily due to its role in activating PKC (Chen et al., 
2000). 
 
Macrophages utilize phagocytic receptors and other pattern recognition 
receptors, such as TLRs, to identify microbes and trigger immune defenses. 
When microbes are engulfed my macrophages, TLR pathways activate the IL-1β 
and inflammatory cytokine promoter, and the full repertoire of immune responses 
is activated, and the IL-6 promoter and an NF-κB reporter are induced. Indeed, 
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TLR pathways are vigorously activated by mycobacterial exposure, but somehow 
some microbes are able to survive the consequences of the wide spectrum of 
cytokines produced. One important mechanism of microbial killing is the 
production of reactive nitrogen species activated by a variety of microbial 
components through TLR pathways. TLR-mediated induction of calcium-
independent nitric oxide synthase (iNOS) is necessary for killing of some 
microbes. In human macrophages, TLR2 activates other potent microbicidal 
mechanisms that are able to kill mycobacteria (Thoma-Uszynski  et al., 2001). 
Microbes may induce iNOS through TLR2/TLR4/MyD88-independent 
mechanisms, suggesting the involvement of receptors other than TLRs. Such 
cross-talk between TLRs and other innate immune recognition receptors has 
long been recognized in killing caused by production of reactive oxygen species, 
where LPS primes activation of phagocyte oxidase induced by phorbol ester or 
by phagocytic particles that do not utilize TLR pathways (Pabst and Johnston, 
1980). 
 
The process of phagocytosis also requires the recruitment of actin filaments for 
the internalization process. This actin recruitment by polymerization/ 
depolymerization exhibits the critical step during the phagocytic process. 
Cytochalasin-D (Cyt-D), known to block actin polymerization by binding to the 
barbed (plus) end of the actin filament, is described as a potent inhibitor of 
phagocytosis (Wakatsuki et al., 2001; Tjelle et al., 2000). During internalization, 
 21 
activated macrophages generate ROS/RNS  under activation of NADPH oxidase 
(Park, 2003). This ROS generation may also act as a second messenger, which 
can trigger several signalling pathways including the activation of NF-κB resulting 
in the production of pro-inflammatory cytokines such as IL-6 and TNF-α (Iles and 
Forman, 2002). 
 
The discussion provided here demonstrates that phagocytosis is an inherently 
complex process that requires coordinated activation of signaling leading to 
events as diverse as actin remodeling, alterations in membrane trafficking, 
particle engulfment, microbial killing, and production of appropriate inflammatory 
mediators that direct the adaptive immune response. The consequences of 
phagocytosis vary, and they depend on the identity of the microbial target and 
the many factors that modulate the activation state of the phagocyte; for 
instance, phagocytosis can induce superoxide formation and apoptosis in 
macrophages (Park, 2003).  
 
Many proteins have been identified that play important roles during phagocytosis, 
and the application of high-throughput technologies is accelerating their 
discovery. A central challenge in anti-inflammatory research will be to integrate 
these molecules into pathways and networks that account for the diversity of 
phagocytic responses. Pathogenic microorganisms have sought out 
vulnerabilities in phagocytic mechanisms in their attempts to subvert defenses, 
and the use of overlapping and redundant mechanisms during phagocytosis may 
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reflect evolutionary pressures for the development of a complex, though highly 
robust system. Studying of these networks and delineation of the phagocytosis 
process is important in defining molecular targets and candidates that can 
regulate macrophage phagocytic activity during inflammation. 
 
1.3 Aryl hydrocarbon receptor (AHR) activation and oxidative stress 
Increasing presence of environmental contaminants and poisonous polycyclic 
aromatic hydrocarbons leads to high incidence rate of contact with these 
toxicants and produces oxidative stress which raises a number of toxic and 
carcinogenic responses in experimental animals and humans mediated for the 
most part by the aryl hydrocarbon receptor (AHR) Barouki et al., 2007). The AHR 
is a ligand-activated transcription factor whose central role in the induction of 
drug-metabolizing enzymes has been well established and widely demonstrated.  
 
It has been widely shown that the AHR molecule also functions in pathways 
outside of its role in detoxification and that modulation of these pathways by 
environmental AHR ligands may be an important part of the toxicity of these 
compounds. The AHR molecule is a cytosolic ligand-activated transcription factor 
that mediates many toxic and carcinogenic effects in animals and possibly in 
humans (Pollenz, 2002). Activation of the AHR pathway in vertebrates causes 
the toxic and carcinogenic effects of a wide variety of environmental 
contaminants such as dioxin (TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin), 
coplanar polychlorinated biphenyls (PCBs) and polycyclic or halogenated 
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aromatic hydrocarbons (PAHs or HAHs). As a consequence of AHR activation, 
many detoxification genes are transcriptionally induced, including those coding 
for the Phase I xenobiotic-metabolizing cytochrome P450 enzymes of which 
CYP1A1 is one the central players.  Other molecules discovered to posess ability 
to bind AHR include indirubin and indirubin-derivatives (Kawanishi et al., 2003).  
 
Indirubin derivatives such as Indirubin-3’-(2,3 dihydroxypropyl)-oximether (E804) 
have been demonstrated to block Stat3 signaling in human breast and prostate 
cancer cells via interactions with AHR. Studies on AHR activation using indirubin 
derivatives demonstrated that although derivatives such 6-Bromoindirubin-3’-
monoxime (BIO) and 5-Iodo-Indirubin-3’-monoxime (5-Iodo) bind to AHR and 
induce its nuclear translocation, they also triggered ARNT-independent nuclear 
redistribution of AHR (Knockaert et al., 2004). Indirubin-3-monoxime is an aryl 
hydrocarbon receptor (AHR)-binding, idole-derived compound known to be a 
potent inducer of CYP1A1, at least in hepatic cell lines and indirubin-3′-
monoxime has been demonstrated to either act as classical AHR ligand, or 
modulates endogenous AHR-regulated activity in U937 histiocytic lymphoma 
cells (Springs and Rice, 2006).  
 
The persistence and prevalence of various exogenous AHR ligands in 
environmental resources necessitates a search for molecules that can inhibit 
AHR-mediated oxidative stress in an attempt to ameliorate AHR-induced disease 
conditions. 
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1.4 Didox as a candidate for regulation of oxidative sress 
Didox(3,4-Dihydroxybenzohydroxamine) is a powerful synthetic antioxidant  and 
one of the most potent ribonucleotide reductase (RR) inhibitors, revealing an 
antitumor effect in several experimental studies and has been shown to have the 
capacity to downregulate NF-κB activation (Elford et al., 2007, Turchan et al., 
2003, and  Inayat et al., 2002). Several lines of research have demonstrated that 
Didox belongs to a unique class of more specific and more potent inhibitors of 
RR enzyme activity than hydroxycarbamides. Furthermore, Didox has has been 
shown to exhibit anti-tumour activity in several tumor models in both in vitro 
studies and in vivo models (Elford et al, 1979; Mayhew et al., 1997, 2002; 
Horvath et al., 2004a,b; Sumpter et al., 2004; Wakisaka et al., 2005).  
 
Phase I trials, as well as phase II clinical studies, in patients with advanced 
breast cancer showed minimal toxicity (Veale et al, 1988; Carmichael et al, 1990; 
Rubens et al, 1991). It is therefore well established that Didox can be tolerated 
by patients at high dosage without major side effect; this makes Didox safe for 
use in clinical applications. Ribonucleotide reductase is a multisubunit enzyme 
responsible for the reduction of ribonucleotides to their corresponding 
deoxyribonucleotides, which are building blocks for DNA replication and repair in 
all living cells. The key role of RR in DNA synthesis and cell growth control has 
made it an important target for anticancer therapy. Increased RR activity has 
been associated with malignant transformation, tumor cell growth and viral 
replication. Based on the critical importance of RR in DNA synthesis and 
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potential as a point of DNA synthesis regulation, efforts for new RR inhibitors 
have been made in basic and translational research and Didox has been in the 
forefront. 
 
Didox has been demonstrated to inhibit oxidative stress and secretion of 
inflammation mediators via suppression of NF-kB activity in various experimental 
models. Didox ability to inhibit this preeminent inflammatory transcription factor, 
NF-κB, is most probably due to its selective inhibition of phosphorylation of the 
cytoplasmic inhibitor IκBα (Lee et al., 2007). In addition to comprising a new 
class of antioxidants, Didox has been shown to be a potent chelator of iron, and 
free radical scavengers (Ding et al., 1992, Elford et al., 1989). Whether these 
interesting properties of Didox have other molecular effects that can be 
potentially therapeutic in the treatment of chronic inflammatory dieases is 
unknown. Didox, for example, protects against reperfusion injury in the rabbit 
heart (Ding et al., 1992). These interesting properties have led us to investigate if 
Didox has other molecular characteristics that are potentially therapeutic, 
especially in disease conditions mediated by deregulated macrophage activation.  
 
Many cancers arise from sites of infection, chronic irritation and inflammation, 
making inflammatory cells (mainly macrophages) an important constituent of the 
tumor microenvironment. The ability of Didox to suppress inflammation and the 
important role of RR in DNA synthesis /repair makes it a worthy candidate and an 
active area of interest for anticancer, antivirus and anti-inflammation research. 
 26 
 
Figure 1.4: A catalog of Didox properties that potentiates them as prolific 
candidates for treatments of inflammatory diseases. Although it was primarily 
synthesized as an inhibitor of ribonucleotide reductase, Didox has been shown to 





Among other characteristics (Fig 1.4) Didox also mediates radiosensitizing 
effects in prostate cancer cells by abrogating the radiationinduced upregulation of 
Bcl-2 expression and NF-κB activity. The properties of Didox that make it a 
worthy anticancer candidate is well-demonstrated in its abilities to interfere with 
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the “Hallmarks of cancer” which explain how cancers acquire their survival 
capabilities. The introduction of adjacent hydroxyl groups increased inhibition of 
RR, and the presence of the hydroxyl-groups in Didox compounds made it active 
against L1210 leukemia. The presence of hydroxyl groups in the structure of 
Didox has been attributed to most its promising therapeutic potential. 
 
Didox has been demonstrated to significantly reduce oxidative stress that was 
present in brain and cerebrospinal fluid (CSF) of HIV-infected patients. HIV-
infected patients with dementia exhibit an accumulation of toxic substances in the 
CSF that are capable of inducing oxidative stress. The anti-inflammatory effect 
observed during treatment of HIV-infected patients using Didox presented it as 
novel compound capable of blocking the CSF-induced toxicity, the therapeutic 
potential of which is worthy of further exploration (Turchan et al., 2003). The 
oxidative stress inhibitory potential of Didox and its ability to attenuate NF-κB 
activity makes it a worthy candidate as a molecule that can modulate 
macrophage activity and its role in inflammation. 
 
As therapeutic choices for the treatment of inflammatory diseases that are 
commonly chronic are coupled with severe side effects, the search for less 
harmful and effective compounds continues to be a strong research area 





DIDOX INHIBITS REACTIVE OXYGEN SPECIES PRODUCTION, 
INFLAMMATORY EVENTS, PHAGOCYTOSIS ACTIVITY AND NF-




Didox (3,4-Dihydroxybenzohydroxamic acid) is a synthetic antioxidant  and one 
of the most potent ribonucleotide reductase inhibitors, revealing an antitumor 
effect in several experimental studies. In humans, tumorigenesis and many other 
diseases which include  atherosclerosis, Parkinson's disease, heart failure, 
myocardial infarction, Alzheimer's disease, and multiple sclerosis have been 
strongly associated with elevated generation of inflammation and oxidative stress 
by aberrant activation of macrophages. The role of Didox on oxidative stress 
events produced in activated macrophages has not yet been fully investigated. 
The first objective was to examine the cytotoxic and cytostatic effect of Didox on 
Raw 264.7 cells so as to establish the optimal concentration to be used. The 
MTT and colony formation assays showed that 100µM Didox was neither 
cytotoxic nor cytostatic to these cells during the 24h period of treatment.  
 
Analysis of more than 200 oxidative stress associated genes using mouse 
oxidative stress, cytotoxicity and NF-κB RT2 ProfilerTM PCR-Arrays revealed that 
100µM Didox treatment of Raw 264.7 macrophages significantly lowered LPS-
induced expression of most inflammatory genes (iNOS, IL-1α, IL-1β, IL-6, TNF-α, 
NF-κB, Cox-2, p38α, TLR4, GM-CSF, G-CSF, CCL2 and CCL4) while 
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upregulating expression levels of most anti-inflammatory genes (Catalase, 
glutathione peroxidase, IL-10, superoxide dismutase, and peroxiredoxins) in 
these cells. Quantitative real-time PCR using selected primers confirmed that 
Didox inhibited LPS-induced mRNA expression of iNOS, IL-6, IL-1, NF-κB (p65), 
Cox-2, and TNF-α in Raw cells while upregulating antioxidant related gene 
(glutathione peroxidase, catalse, and superoxide dismutase) expression after 
24h of treatment.  
 
Moreover, using the sandwich ELISA assay, it was demonstrated that Didox 
dose-dependently inhibits LPS-induced IL-6 production in Raw 264.7 cells. 
Western blot analysis showed that Didox suppressed LPS-induced protein 
expression of Cox-2, iNOS, and TNF-α in Raw 264.7 macrophages. The Griess 
reagent and DAF-2 DA assays showed that Didox inhibits LPS-induced secretion 
and production of nitric oxide in Raw 264.7 cells. Didox also inhibited LPS-
induced reactive oxygen species (ROS) production as assessed with the 
dihydrodichlorofluorescein diacetate (CM-H2DCFDA) assay and evaluated using 
Fluorescence Microscopy Analysis. Didox further blocked Buthionine Sulfoximine 
(BSO) and LPS-induced ROS production in Raw 264.7 murine macrophages.  
LPS-mediated oxidative burst and superoxide free radical productions in Raw 
264.7 macrophages were also suppressed by addition of Didox as demonstrated 
using the DHE assay. 
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In additional functional assays, Didox inhibited both LPS-induced endocytosis of 
FITC-labeled beads and phagocytosis of TRITC-labeled yeast cells in Raw 264.7 
murine macrophages. Immuonofluorescence translocation studies with FITC-
labeled NF-κB (p65) and Western blot analysis showed that Didox inhibited LPS-
induced p65 nuclear translocation in Raw 264.7 cells. These results suggest that 
the pharmacological action of Didox observed in Raw 264.7 murine 
macrophages is partly due to its potent anti-oxidative effects and anti-
inflammatory potential, and that these actions may be mediated via inhibition of 
the NF-κB pathway. Didox may therefore play a major in managing disease 
conditions exacerbated by of LPS-induced oxidative stress in macrophage-
mediated inflammation. 
 
ABBREVIATIONS: Didox, 3,4-Dihydroxybenzohydroxamic acid; NO, Nitric oxide; 
iNOS, inducible nitric-oxide synthase; LPS, lipopolysaccharide; NF-κB, nuclear 
factor-κB, MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; 
H2DCFDA, 2’7’-dihydrodichlorofluorescein diacetate; BSO, buthionine 
sulfoximine; IL-6, interleukin 6; ROS, reactive oxygen species; FITC, fluorescein 
isothiocyanate, MFI, mean fluorescence intensity; DHE, dihydroethidium; DAF-2 







Reactive oxygen species (ROS) are a cluster of highly unstable compounds that 
are generated during inflammation and normal cellular metabolism via 
incomplete reduction of molecular oxygen. They consist of molecules with 
unpaired electrons such as superoxide anions (O2
− ) and hydroxyl radical ( OH), 
and molecules that have oxidizing propensity but do not possess free electrons, 
for example hydrogen peroxide (H2O2) and hypochlorous acid (HOCl) (Abid et al., 
2005) . These species are involved in the regulation of fundamental cellular 
activities such as cell growth and differentiation (Dor and Porat, 2001; D'Angio 
and Maniscalco, 2002, Hopf et al., 2005 , and Veal et al., 2007). However, their 
overproduction and/or the presence of impaired antioxidant ability results in 
oxidative stress which can induce and propagate significant injury. Likewise, 
reactive nitrogen species (RNS), the by-products of nitric oxide (NO) metabolism, 
play an important role in maintaining various physiological functions at basal 
levels, and contribute to several pathological processes at high levels. Examples 
of RNS include nitrite (NO2
-), nitrate (NO3
−) and peroxynitrite (ONOO−) and these 
are produced in large amounts during the process of inflammation (Boueiz and 
Hassoun, 2009). 
Inflammation is a complex stereotypical response of the body to cell damage and 
breaches in vascularized tissues. The inflammatory response is phylogenetically 
and ontogenetically the oldest defense mechanism that is controlled by 
cytokines, products of the plasma enzyme systems, lipid mediators released from 
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different cells, and by vasoactive mediators released from mast cells, basophils 
and platelets (Ross et al., 2002).  However, deregulated inflammatory processes 
induce overproduction of ROS/RNS and reduced cellular antioxidant capacity 
leading to cellular oxidative stress. Cellular oxidative stress can be a 
predisposing factor for cancer and inflammation-based disorders since it results 
in oxidation of DNA, lipid bilayer fatty acids and proteins impairing their function 
permanently. By oxidizing these vital molecules, oxidative stress can lead to DNA 
mutation or damage, lipid peroxidation, protein degradation, and these factors 
have been associated with inflammatory diseases such as  atherosclerosis, 
multiple sclerosis, Parkinson's disease, heart failure, myocardial infarction, 
Alzheimer's disease, chronic fatigue syndrome, and cancer (Khansari et al., 
2009).  
 
A key player in inflammation is the macrophage whose wide tissue distribution 
makes them well suited to provide an immediate defense against foreign 
elements prior to leukocyte migration (Zhang et al., 2008). As macrophages 
participate in both adaptive immunity and innate immunity against bacterial, viral 
and fungal pathogens, they display a range of functional and morphological 
phenotypes. The murine macrophage Raw 264.7 cell lines are the best model for 
these studies since its lipopolysaccharide (LPS) -induced state exhibits these 
typical functional and morphological phenotypes. LPS triggers the secretion of 
nitric oxide (NO) and inflammatory cytokines through stimulating intracellular 
signaling molecules such as Nuclear factor-κB (NF-κB) and mitogen-activated 
 33 
protein kinases (MAPKs) (Xie et al., 1994). Previous studies have suggested that 
these LPS-induced pathways play a critical role in LPS-induced iNOS and IL-6 
expression (Nam et al., 2007, Cho et al., 2003, Kim et al., 2006). 
 
Nitric oxide, a small-molecule and membrane-permeable gas released by 
activated macrophages, mediates many physiological events, and chronic 
elevated nitric oxide is involved in the deamination of DNA and inactivation of 
DNA repair enzymes, mechanisms that induce cancer (Kim et al., 2007, Kim et 
al., 2004). Endothelial NO synthase (eNOS), neuronal NO synthase (nNOS), and 
inducible NO synthase (iNOS) are the three key enzymes that generate nitric 
oxide. iNOS is responsible for the overproduction of nitric oxide and is often 
present during inflammation and carcinogenesis (Fukumura et at., 2006). 
Expression of the iNOS gene in macrophages is regulated mainly at the 
transcriptional level, particularly by NF-κB (Xie et al., 1994).  
 
In unstimulated cells, NF-κB is constitutively localized in the cytosol as a 
homodimer or heterodimer, and is associated with inhibitory IκB protein (IκB). 
Activation of NF-κB is induced by phosphorylation of IκB, leading to its 
degradation and to the translocation of NF-κB to the nucleus (Griscavage et al., 
1996). In this way, NF-κB regulates the inflammatory reaction by increasing the 
expression of specific cellular genes (Yamamoto et al., 2001). Just like many 
other NF-κB regulated genes there are NF-κB consensus DNA sequences within 
the iNOS promoter (Yeo et al., 2003) that are responsible for LPS-induced NF-κB 
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DNA binding activity. As a result, inhibition of signal transduction proteins in the 
pathways leading to activation of NF-κB is now widely recognized as an 
applicable strategy to combat inflammatory disease.  
 
While therapeutic choices for the treatment of commonly occurring chronic 
inflammatory diseases are coupled with severe side effects, the search for less 
harmful and effective compounds continues to be a strong research area 
(McKellar et al., 2007). Didox(3,4-Dihydroxybenzohydroxamine) is a simple, 
synthetic antioxidant  and one of the most potent ribonucleotide reductase 
inhibitors, revealing an antitumor effect in several experimental studies and has 
been shown to have the capacity to downregulate NF-κB activation (Elford et al., 
2007, Truchan et al., 2003, and  Inayat et al., 2002). We have therefore 
examined the effect of Didox on LPS-induced oxidative stress in Raw 264.7 
murine macrophage cell line and show that it possesses potent anti-oxidative and 
anti-inflammatory effects, and that these actions are mediated via inhibition of the 
NF-κB pathway. These results suggest that Didox may therefore play a major 








MATERIALS AND METHODS 
 
Materials 
Didox was provided by Dr. Howard Elford, Molecules for Health Inc. (Richmond, 
VA) and phorbol-12-mristate-13-acetate (PMA) was purchased from A.G. 
Scientific Inc., San Diego, CA. LPS from E. coli serotype R515(Re) (ultra pure, 
TLR4grade™) was purchased from Alexis biochemicals, San Diego, CA and FBS 
from Atlas Biological, Fort Collins, CO. Dulbecco's Modified Eagle Medium 
(DMEM), fetal bovine serum (FBS), HEPES, glucose, sodium bicarbonate, 
penicillin, streptomycin, paraformaldehyde, Triton X-100 , Sodium Borohydride, 
buthionine sulfoximine and dimethyl sulfoxide (DMSO Hybri Max®) were 
purchased from Sigma, St Louis, MO. H2DCFA, DHE, DAF-2 DA (Molecular 
Probes, Eugene, OR) , rabbit anti-65 polyclonal antibody (Thermo Fisher Sci., 
Fremont, CA), goat-anti rabbit polocylonal Ab, Raw 264.7 murine macrophage 
cells (ATCC®, Manassas, VA) , RT2 Profiler™ PCR Array System, RT2 First 
Strand Kit and RT2 qPCR Master Mix were purchased from SABiosciences 
Corp., Frederick, MD, PCR primers  from IDT®, Coralville, IA, TRI-reagent® from 
Molecular Research Center, Inc.Cincinnati, OH and Halt™ Protease Inhibitor 
Cocktail from Thermo Fisher Sci., Rockford, IL. All other chemicals were 






Murine macrophage RAW 264.7 cells were cultured in Dulbecco’s modified 
Eagle’s medium (DMEM) containing 25 mM HEPES buffer, 3 g/L D-glucose, 1.5 
g/L sodium bicarbonate and 4 mM L-glutamine. The culture media were 
supplemented with 10% fetal bovine serum, penicillin (100 units/ml) and 
streptomycin (100 µg/ml). All cultures were maintained in a humidified incubator 
in 5% CO2 at 37 °C and cells were be split for sub-culturing two times a week. 
 
Treatment Preparations 
Didox (3,4-Dihydroxybenzohydroxamine) was dissolved in dimethyl sulfoxide 
(DMSO Hybri Max®  purchased from Sigma, St Louis, MO)  to a final stock 
concentration of 200 mM and further diluted in culture medium to the working 
serially diluted concentrations ranging from 3.12 – 200 µM. LPS (E. coli, 
Serotype R515 ultra-pure, TLR4 gradeTM purchased from Alexis Biochemicals, 
San Diego, CA) was diluted in serum-free culture medium before adding to 
culture treatments. 
 
Determining cell cytotoxicity using MTT Assay 
Cell viability was determined via MTT [3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide] assay which is based on the capacity of 
mitochondrial succinyl dehydrogenase of viable cells to convert the soluble 
yellow tetrazolium salt into an insoluble formazan product. Briefly 100 µl of cells 
were seeded at 10 5 cells/well in 96-well plates and allowed to adhere for 3 h, 
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thereafter  Didox or LPS treatment was added to wells to give the desired final 
concentrations as indicated under the figure legend. Controls without treatment 
were run in parallel. Following a 24h or 48h incubation period with or without 
treatment, 20 µl of a 5 mg/ml solution of MTT (Sigma, St Louis, MO) in 
phosphate buffered solution (PBS) was added in the medium and the cells were 
further incubated for 1 h at 37 °C. The culture medium was then completely 
removed by aspiration and the dark blue crystal formazan resulting from the 
reduction of MTT was dissolved by adding 200 µl of dimethyl sulfoxide (DMSO) 
and the plates were left on a shaker for another 20 minutes. The optical density 
(OD) was measured at 570 nm using a 96-well plate reader (µ-Quant, Bio-Tek 
Instruments, Inc.) and cell proliferation was estimated as the percentage 
absorbance of sample relative to control. All treatments and controls were 
carried-out in triplicates and repeated three times to confirm reproducibility. 
 
Cell staining for apoptotic nuclear morphology using Hoechst/PI double 
stain.  
RAW 264.7 cells were plated on glass cover-slips at a density of 1 × 106 cells/60-
mm dish and allowed to adhere for 3hr. Cells were then treated with media alone 
or the combination of Didox (100 µM) and LPS (0.1 µg/ml) for a period of 24 hr 
and then stained with Hoechst/PI regimen. Briefly, at 24 hr after treatment, the 
cell media were removed by aspiration and the adhered cells were resuspended 
in 500 µl of Hoechst 33342 dye (5 µg/ml). Cells were incubated for 15 min at 
37°C followed by gentle addition of propidium iodide (10 µg/ml).  The cells were 
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then fixed as described above and mounted on glass slides for imaging using 
epifluorescent microscope. 
 
Gene Analysis using RT2 ProfilerTM PCR-Arrays.  
Murine macrophage RAW 264.7 cells were seeded at 5 X 106 cells/ml in 75 cm2 
culture flasks (Corning Inc., NY) and allowed to adhere to flask surfaces to 3h. 
Cells were then treated with Didox (100 µM) and RNA was extracted from cells 
after 24h using TRI-reagent® from Molecular Research Center, Inc.( Cincinnati, 
OH) and retrotranscribed by RT-PCR first strant kit (SuperArray Bioscience 
Corporation, Frederick, MD). To isolate RNA the cells were scraped from flask 
surface using BD FalcomTM cell scraper (BD Biosciences, Bedford, MA) and 
harvested by centrifugation. TRI-reagent® was added (1ml) to all cell pellets and 
the mixture was homogenized by slow pippeting several times. The homogenate 
was then incubated at room temperature for 5 min with addition of 0.2 ml 
chloroform.  
 
After incubating the mixture at room temperature for 15 min, the samples were 
centrifuged at 12,000 x g, for 15 min at 4 °C. The aqueous phases were 
transferred to a new 1.5 ml microcentrifuge tube. RNA from the aqueous phase 
was precipitated by mixing with 0.5 ml isopropyl alcohol with incubation at room 
temperatue for 10 min, and centrifuged at 12,000 x g for 15 min at 4 °C. 
Precipitated RNA pellets were washed three times with 70% ethyl alcohol, and 
redissolved in DEPC-treated water. After collecting 1µg RNA from each tube, 
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Genomic DNA contamination was eliminated by using Genomic DNA elimination 
mixture (SuperArray Bioscience Corporation, Frederick, MD) and cDNA 
synthesis was carried using the RT cocktail (SuperArray Bioscience Corporation, 
MD). Real-time PCR was then performed on BioRad iQ5 real-time PCR detection 
system (Applied Biosystems) using Mouse Oxidative Stress RT2 Profiler PCR 
Array and RT2 Real-Timer SyBR Green/qPCR Master Mix purchased from 
SuperArray Bioscience Corporation (Frederick, MD). For data analysis the ∆∆Ct 
method was used; for each gene fold-changes were calculated as difference in 
gene expression between untreated controls and treated cell cultures. A positive 
value indicates gene up-regulation and a negative values indicate gene down-
regulation. 
 
RT-PCR validation assays 
To validate the results obtained from the PCR Array, RNA was extracted and 
cDNA obtained from treated murine macrophages as mentioned above. mRNA 
levels were analysed by by real-time PCR using the following conditions: 1 cycle 
at 95°C for 10 min, 40 cycles at 95°C for 15 sec, 55°C for 1 min and quantified 
using selected primers (Table 2.1). The quantity of these mRNAs was expressed 
as fold-changes compared to the untreated Raw 264.7 murine macrophage 








Table 2.1: Primer sequences used for of Real Time-PCR evaluation of 


















R: 5'-CGGGGACCAAATGATGTA CT-3' 
SOD1 
F: 5'-CGGATGAAGA GAGGCATGTT-3' 
R: 5'-CACCTTTGCCCAAGT CATCT-3' 
CAT 
F: 5'-TTGACAGAGAGCGGA TTCCT-3' 














Measurement of NO production using nitrite assay 
For evaluating the possible effect of Didox on LPS-induced NO production, Raw 
264.7 cells in MEM (without phenol red) media were plated at a density of 105 
cells/well in 96-well culture plate and grown for 3 h to allow them to attach to the 
plate. Didox was added to the wells at desired final concentrations in the 
absence or presence of LPS (0.1µg/ml). The cells were further incubated for 24 
h.  Control cells were grown under identical conditions except without tested 
compounds. After that, the supernatants were collected for determination of 
nitrite as an index for nitric oxide (NO) production. NO synthesis in cell culture 
was measured using Griess reagent. Briefly, 100µl/well of sample was incubated 
with equal volume of Griess solution (0.1% naphthylethylenediamine and 1% 
sulfanilamide in 5% H3PO4 solution) at room temperature for 10 min. The 
absorbance was measured with a 96-well plate reader (µ-Quant, Bio-Tek 
Instruments, Inc.) at 550 nm. Nitrite concentration was determined by using 
sodium nitrite as a standard. The level of nitrite, a more stable NO metabolite, 
reflects NO synthesis since NO has a very short half-life. 
 
Determination of IL-6 production by murine macrophage Raw 264.7 cells 
After treatment of cells in the 96-well plates and incubation at appropriate time 
intervals, cell culture supernatants were removed for cytokine determination 
assays. The cell culture supernatants were collected and analyzed for IL-6 
proteins using commercial ELISA kits Mouse IL-6 ELISA Ready-SET-Go! 
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(eBioscience, San Diego, CA). The protocols provided by the manufacturers 
were followed to the detail. Briefly, NUNC Maxisorp 96 well ELISA plates were 
coated with 100µl/well of capture antibody overnight and after five washes, 
100µl/well of detection antibody is added followed by 1h incubation at room 
temperature. After proper washing, avidin-HRP (horse radish peroxidase) was 
added at 100µl/well and incubated plate at room temperature for 30 minutes. The 
avidin-HRP was replaced with substrate solution for 15 minutes and after 
addition of a stop solution the optical density (OD) can be measured at 450 nm 
using an ELISA plate reader (µ-Quant, Bio-Tek Instruments, Inc.). IL-6 protein 
concentration was quantified from a standard curve constructed from serially 
diluted standard concentration readings in appropriate wells. All treatments and 
controls were carried in duplicates and repeated three times to confirm 
reproducibility. 
 
Evaluation of ROS production using fluorescent microscopy  
Cells were seeded at 5 x 105 cells/well in eight chamber cell culture slides for 3h 
and then treated with Didox (100µM), BSO (400µM) in the presence or absence 
of LPS (1µg/ml). After 24h incubation, H2DCFA solution was added at 10
 µM to 
all wells and incubated for an additional 30 min at 37˚C. The slides were washed 
twice with PBS, fixed with chilled absolute methanol for 1 min and mounted using 
glycerol:PBS (1:1) solution. The cover slips were placed over the mounting 
medium and the slides sealed using nail polish. The slides were then viewed 
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under the fluorescence microscope and images capture using the digital camera 
with quantification done using the Nikon NIS elements software. 
Assessment of intracellular superoxide radical production in Raw 264.7 
cells. 
Superoxide production in Raw cells was assayed by using the oxidative 
fluorescent dye DHE. DHE is oxidized on reaction with superoxide to ethidium 
bromide, which mostly binds to DNA in the nucleus and fluoresces red. Cells 
were seeded on cover slips at 2 x105 cells/well (in 6-well plates) for 3hrs. To 
quench out any residual fluorescence, cells were treated with 0.01% sodium 
borohydride (in PBS) for 5 min. After loading cells with 10 µM DHE for 15min, 
cells were treated for 24h with 100 µM Didox in the presence or absence of LPS 
(0.1µg/ml). Cells were fixed and mounted on slides and analyzed using the Nikon 
AZ100 Epi-Fluorescent Microscope. The un-oxidized DHE remains blue (λEx\Em 
=355\420nm) while the oxidized DHE fluoresces red (λEx\Em=355\420nm). Images 
were captured using the NIS-Elements Viewer 3.0. 
 
Intracellular NO production and iNOS activity in Didox-treated Raw 264.7 
murine macrophages. 
4,5-Diaminofluorescein Diacetate (DAF-2 DA), can be used for real-time 
bioimaging of NO with fine temporal and spatial resolution. A membrane-
permeable DAF-2 DA is hydrolyzed by cytosolic esterases releasing free DAF-2 
DA that does not leak into the medium. At physiological pH, the DAF-2 is 
relatively non-fluorescent, however, in the presence of NO and oxygen, DAF-2 
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triazole (DAF-2T), a fluorescent product, is formed. Cells were seeded on cover 
slips at 2 x105 cells/well (in 6-well plates) for 3hrs. To quench out any residual 
fluorescence, cells were treated with 0.01% sodium borohydride (in PBS) for 5 
min. After loading cells with 10 µM DAF-2 DA for 15min, cells were treated for 
24h with 100 µM Didox with or without LPS (0.1 µg/ml). Cells were fixed and 
mounted on slides and analyzed using the Nikon AZ100 Epi-Fluorescent 
Microscope. 
 
Western Blot Analysis 
Murine macrophage RAW 264.7 cells were seeded in 6-well plates to final 
volume of 5ml  at 2.5 x 106 cells/ml and incubated at 37ºC for 3 h before 
treatment with Didox or LPS. After treatment the culture medium was replaced 
with 500 µl of Lysis Buffer (50 mM Tris base, pH 8, 150 mM NaCl, 1% IGEPAL 
CA 630, 0.1 % SDS, Protease Inhibitor cocktail) and cells lysed on ice for 30 min 
with constant shaking. The lysates were then transferred to 1.5 ml microfuge 
tubes and the insoluble membrane fraction separated from the soluble fraction by 
centrifuging at 10,000 x g for 10 minutes. The soluble fraction was mixed with 
sample buffer and boiled for 10 minutes.  
 
Electrophoresis was performed using 4-20% TBE CititerionTM Precast Gels (Bio-
Rad Lab, Inc. Hercules, CA) for 1 hr (200 V, 1 µg protein per lane) in electrode 
buffer (25 mM Tris base, 190mM Glycine, 0.1% SDS). Separated proteins were 
transferred to nitrocellulose membranes for 1hr (<100kDa) or overnight 
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(>100kDa) at 100V or 30V respectively in transfer buffer  (25 mM Tris, 190 mM 
Glycine, pH 8.1-8.4) followed by incubation in 0.01M PBS containing 0.1% 
Tween 20, 3% BSA, and 0.1% gelatin to block nonspecific IgG binding, followed 
by treatment with specific primary antibodies for 30-45 min. The membranes are 
then incubated with alkaline phosphatase-conjugated secondary antibody for 30-
45 min. The Western blot analysis was developed using substrate buffer [0.1 M 
Tris buffer, 0.1M NaCl, 5 mM MgCl2  pH 9.5, mixed with 1% NBT:BCIP (2:1)]. 
 
Preparation of cytosolic and nuclear extracts 
For cytosolic protein extraction, Raw 264.7 macrophages were resuspended in 
500 µL of buffer A (10 mM HEPES, 10 mM KCl, 1 mM MgCl2, 5% glycerol, 0.5 
mM EDTA, 0.1 mM EGTA, 1X protease inhibitor solution, 2 mM PMSF and 0.5 
mM DTT) and  incubated on ice in slow shaker for 15 min followed by addition of 
0.65% of NP-40 . The mixture was vigorously vortexed for 10s and centrifuged at 
12,000 x g for 1 min. For nuclear protein extraction, the resulting nuclear pellets 
were resuspended in 500 µL of high salt buffer B (20 mM HEPES, 1% NP-40, 
400 mM NaCl, 10 mM KCl, 1 mM MgCl2, 20% glycerol, 0.5 mM EDTA, 0.1 mM 
EGTA, 1X protease inhibitor solution, 2 mM PMSF and 0.5 mM DTT) and 
incubated on ice in slow shaker for 1 hr. The mixture was vigorously vortexed for 





NF-κB translocation immunofluorescence assay 
Raw 264.7 murine cells were cultured in 8-chamber slides at 2 x105 cells/well 
and seeded for 3hrs before treatment with Didox, LPS or combination of both for 
90 min. After fixation with 4% PFA cells were permeablized with 0.1% Triton X-
100, 1%BSA for 30 min. Any possible background fluorescence was quenched 
by incubating cells in 0.01% sodium borohydride (in PBS) for 5 min and non-
specific binding sites were blocked by adding 1% BSA with 1 hr incubation. Cells 
were incubated for 60 min with rabbit anti-p65 antibody (1:1000) (purchased from 
Thermo Fisher Sci., Fremont, CA) followed by FITC-labeled goat anti-rabbit 
secondary Ab incubation for 60 min.  After 5 min nuclear staining with DAPI cells 
were mounted on slides using 50% glycerol and analyzed using the Nikon AZ100 
Epi-Fluorescent Microscope. Images were captured using the NIS-Elements 
Viewer 3.0. 
 
WEHI Bioassay for TNF-α production 
The  production of TNF-α by Raw 264.7 macrophages can be evaluated further 
using a bioassay which measures the cytotoxicity of this cytokine on TNF-α 
sensitive WEHI-164 cells. The WEHI 164 fibrosarcoma cell line assay described 
below can be used for assaying TNF-α by measuring cell survival after treatment 
with supernatants obtained from Raw 264.7 cells. TNF-α induces cell death via 
apoptosis in WEHI-164 cells and this assay was used to analyze the production 
and secretion of bioactive TNF-α. Raw 264.7 murine macrophages were treated 
with Didox, LPS or their combination for 24h and the supernatants were 
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collected. WEHI-164 cells were cultured cells in 96 well plates at 5 x 104 
cells/well and incubated for 2-3h in 37◦C humidified incubator to allow adherence 
to the plate surface. Several 1:5 dilutions of supernatants collected from Raw 
cells conditioned media were added in triplicate wells containing seeded WEHI 
cells and further incubated for 24h in 37◦C humidified incubator with 5% CO2. 
Afterwards the media was aspirated and replaced with MTT working solution (5 
mg/ml) and incubated for incubate for 4h at 37◦C until the blue formazan was 
visible. The MTT was then aspirated and DMSO was added to solubilize the 
formazan on shaker for 10 min. The absorbance was read at 570nm and the 
percentage of surviving cells was calculated in comparison with control cells. 
Control cells were established by treating WEHI cells with supernatants obtained 
from untreated Raw 264.7 cells. The assay was repeated three times and a 
representative image of cells was photographed using the Nikon AZ100 
Microscope. 
 
Bioassay for IL-6 production using B9 cell lines 
The production of IL-6 by Raw 264.7 macrophages was evaluated using a 
bioassay which measures the proliferative effect of this cytokine on IL-6 
dependent B9 cell lines. The IL-6 dependent murine hybridoma cell line B9 
provides a reliable and sensitive assay for measuring IL-6 production in 
mammalian cultures. B9 cells were cultured in RPMI-1640 medium 
supplemented with 10% FBS and IL-6. For the bioassay, B9 cells were washed 
and seeded to a density of 2.5 x 104 cells/well in 96-well microtiter plates. A 1:5 
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dilution of supernatants obtained from Didox (100 µM) and LPS (0.1 µg/ml) 
treated Raw cells was added in triplicates and incubated for 24h in a 37◦C 
humidified incubator with 5% CO2. B9 cells treated with cultured media alone 
were used as negative controls. Afterwards the plates were centrifuged at 500 x 
g for 10 min to pellet cells and media was aspirated to be replaced with MTT 
working solution (5 mg/ml) and incubated for incubate for 4h at 37◦C until the blue 
formazan was visible. The MTT was then aspirated and DMSO was added to 
solubilize the formazan on shaker for 10 min. The absorbance was read at 
570nm and the stimulation index was calculated in comparison with control cells. 
Control cells were established by treating B9 cells with supernatants obtained 
from untreated Raw 264.7 cells. The assay was repeated three times and a 
representative image of cells was photographed using the Nikon AZ100 
Microscope. 
 
Phagocytosis  Assay (Microscopic analysis using FITC-beads) 
For determination of effect of Didox of macrophage functionality, Raw 264.7 
murine macrophages were seeded at 105 cells/well in 8-chamber glass slides 
and incubate for 3hrs followed by treatment with LPS (0.1µg/ml), CytA (1 µM) 
and Didox (100µM) for 30 min. FITC-labelled beads were added at 0.1 mg/ml or 
106 particles per well and incubated for 30 min in 37◦C incubator.  After washing 
with PBS, 100 µl Trypan blue (2 mg/ml in 20 mM citrate, 150 mM NaCl, pH 4.5) 
was added to quench extracellular FITC beads for 2 minutes. Cells were fixed by 
incubating in 4% PFA for 30 min and mounted onto coverslip using 50 % glycerol 
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(in PBS). Sealing was done using colorless clear nail polish and cells were 
evaluated using the Nikon AZ100 Epi-Fluorescent Microscope and images 
captured using the NIS-Elements Viewer 3.0. The percentage of phagocytosis of 
FITC-labeled beads was quantified microscopically by counting at least 100 cells 
in randomly selected fields per well, and an average between the duplicate wells 
was calculated. Phagocytic index was calculated as: (average number of beads 
phagocytosed per macrophage) x (% macrophages that had phagocytosed one 
or more beads). 
 
Statistical Analysis 
All experiments are representative of three repeats carried out in triplicates and 
the error bars represent the standard deviation from the mean average. All data 
representations were analyzed using Graphpad PRISM 4.0 (Graphpad, San 





Determination of effect of Didox on Raw 264.7 cell viability. 
The effect of Didox on Raw 264.7 cell viability was determined by the 
mitochondrial-dependent reduction of yellow MTT [3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazoliumbromide] to blue formazan. Raw 264.7 murine 
macrophages were seeded at 105 cells/well in 96-well plates for 3h and then 
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treated with increasing concentrations of Didox (0-200µM) in the presence or 
absence of LPS for 24h. Replacing the media with MTT solution revealed that 
cell viability was maintained above 90% at the concentrations tested with no 
significant indication of cytotoxicity (Fig 2.1) and the PI exclusion assay showed 
that cells exhibited no signs of apoptosis (Fig 2.2). To further evaluate cell 
integrity and long-term effect of Didox on Raw 264.7 murine macrophages, 
microscopic images of cells were captured at 12h intervals for up to 72h with no 























































Figure 2.1. Effect of Didox on cell viability of LPS-stimulated Raw 264.7 murine 
macrophages.  Raw 264.7 murine macrophages were incubated with Didox (0-200µM) 
and LPS (0.1µg/ml) for 24h and cell viability was quantified using the MTT assay. Each 




Figure 2.2. Didox-treated Raw 264.7 macrophages exclude PI dye and exhibit no signs of 
apoptosis during 24h period.  Raw 264.7 murine macrophages were seeded on 
coverslips and incubated with Didox (100µM) and LPS (0.1µg/ml) for 24h followed by 
incubation with PI/Hoechst 33342 stain. Each value represents the mean ± SD of three 
experiments performed in triplicates. After mounting, slides were view under fluorescent 




Figure 2.3. Didox exhibits no cytostatic effect on Raw 264.6 cells for up to 48h of 
treatment. Raw 264.7 macrophages were seeded at 5 x 104 cells/well on coverslips in 6-
well plates and incubated with Didox (100µM) and LPS (0.1µg/ml) for up to 48hr and 
growth was monitored  every 12h using microscope DIC filter and images captured using 









Analysis of oxidative stress associated genes using mouse oxidative 
stress, cytotoxicity and NF-κB RT2 ProfilerTM PCR-Arrays. 
Quantification of oxidative stress-associated genes is an important element in 
studies of inflammation and immune responses. Quantitative RT-PCR, a rapid 
and sensitive assay, is the preferred method to quantify gene mRNA levels 
because they are often expressed at low levels. The PCR Array System offers a 
simple, reliable and sensitive tool for multiple gene profiling. Using the Mouse 
Oxidative stress and NF-κB PCR Array, the mRNA levels of 84 different oxidative 
stress-related genes in LPS-stimulated and untreated Raw 246.7 murine 
macrophage cells versus their Didox-treated (100µM) counterparts were 
monitored. The gene expression results identified a number of up-regulated and 
down regulated genes upon 24 h of treatment. At 24 hours, the positive effects of 
LPS on pro-oxidant genes such as CSF’s, Chemokines, TLR’s, IL1a, IL1β, IL6, 
iNOS, NF-κB(p105) and TNF were observed, while its inhibitory effect on anti-
oxidant related genes such as IL-10 and Gpx2 was evident twenty-four hours 
after stimulation (Table 2.2). Didox treatment lowered expression levels of most 







Table 2.2 A-D. Downregulation of oxidative stress associated mRNA gene levels by 
Didox in LPS-stimulated raw 264.7 murine macrophages. The Mouse Oxidative stress 
and NF-κB PCR Array was used to evaluate the mRNA levels of 84 different oxidative stress-
related genes in Raw 246.7 murine macrophage cells treated with LPS(0.1µg/ml), Didox 
(100µM), or both. PCR was performed on BioRad iQ5 real-time PCR detection system as 
indicated in the methods. For data analysis the ∆∆Ct method provided by SABioscience was 
used; for each gene fold-changes were calculated as difference in gene expression between 
untreated controls and treated cell cultures. A positive value indicates gene up-regulation 




A. Oxidative stress associated genes  
GenBank  Acc. No.  Gene Name  DX  LPS  LPS+DX  
NM_011611  Cd40  -2.81  7.37  3.76  
NM_011333  Ccl2  -4.12  23.40  -1.54  
NM_011337  Ccl3  -1.57  6.93  1.65  
NM_009969  Csf2  -3.42  6.30  1.81  
NM_009971  Csf3  -13.47  92.33  3.14  
NM_009652  Akt1  -8.35  4.14  -2.91  
NM_010336  Edg2  2.17  3.02  6.30  
NM_021274  Cxcl10  -5.98  3.23  -4.86  
NM_030677  Gpx2  2.25  -3.09  5.23  
B. NF-κB transcription factor associated genes  
GenBank  Acc. No.  Gene Name  DX  LPS  LPS+DX  
NM_008689  NFκB1  -2.70  1.09  -1.62  
NM_019408  NFκB2  -2.77  1.45  1.00  
NM_009045  RELA  -1.91  1.13  -4.12  
NM_033601  BCL3  14.73  4.06  18.09  
 56 
C. Inflammation-associated cytokines  
GenBank  Acc. No.  Gene Name  DX  LPS  LPS+DX  
NM_010548  IL10  1.34  -1.50  1.35  
NM_010554  IL1α  -4.45  7.23  5.49  
NM_008361  IL1β  -7.35  6.75  5.59  
NM_008362  IL1R1  -1.74  10.35  2.70  
NM_031168  IL6  -9.26  26.49  7.21  
NM_013693  Tnf  -4.33  1.47  -3.63  
NM_009425  Tnfsf10  -1.81  7.72  1.24  
 
 
D. Toll-like Receptor associated genes  
GenBank  Acc. No.  Gene Name  DX  LPS  LPS+DX  
NM_126166  TLR3  -1.11  4.98  3.40  
NM_021297  TLR4  -2.84  2.75  -2.07  
NM_008363  IRAK1  -1.61  9.71  -2.11  
NM_172161  IRAK2  -1.88  3.08  -1.63  
NM_011945  MAP3K1  -1.36  2.71  -1.78  
NM_011952  MAPK3  1.10  5.15  1.12  







Validation of RT-PCR array results of selected genes using specific 
primers. 
To validate the results obtained using the RT2 ProfilerTM PCR-Arrays, an 
additional RT-PCR analysis was carried out using selected primers to evaluate 
the expression levels of genes involved in inflammatory pathways. These RT-
PCR assays showed that LPS-treatment increases mRNA expression levels of 
NF-κB (p65), TNF-α, iNOS, IL-6, and Cox-2 genes (Fig 2.4A-E). On the other 
hand, addition of Didox reduced expression of these LPS-induced mRNA 
expression levels after 24h of treatment. Didox treatment of Raw 264.7 murine 
macrophages led to upregulated mRNA expression levels of antioxidant-related 



















Figure 2.4: Real-time PCR data showing modulation of antioxidant and oxidative 
stress associated mRNA gene levels in LPS-stimulated Raw 264.7 murine 
macrophages by Didox. RT-PCR was conducted using cDNA from LPS-stimulated Raw 
264.7 murine macrophages treated with Didox (100 µM) for 24h. Primers used are outlined 
in Table 1. LPS-treatment increases mRNA expression levels of iNOS (A), IL-6 (B), TNF-α 
(C), Cox-2 (D), and NF-kB(E) with variable inhibition by Didox. Didox treatment upregulated 
mRNA expression of Gpx1 (F), SOD1 (G), and Cat (H). Each value represents the mean ± 


















Didox inhibits LPS-induced NO secretion in Raw 264.7 murine 
macrophages. 
Activated macrophages produce NO in large amounts during LPS-stimulation 
and inflammatory responses. Since NO production is mediated by iNOS and RT-
PCR results indicated an inhibitory role of Didox on iNOS mRNA expression, it 
was important to evaluate the effect of Didox on NO production in these LPS-
activated macrophages. To assess the effect of Didox on LPS-induced NO 
production in RAW 264.7 macrophages, cell culture medium was harvested after 
treatment, and the concentration of accumulated nitrite, the oxidative product of 
NO, was determined by the Griess method. Didox significantly (p<0.01) inhibited 
LPS-induced NO release in RAW 264.7 cells in a concentration-dependent 
manner (Fig 2.5). Didox at 100µM significantly decreased NO production while 
maintaining cell viability of Raw 264.7 macrophages around 100% and although 

















Didox suppresses intracellular NO production and iNOS activity in LPS-
induced Raw 264.7 murine macrophages. 
For direct measurement of intracellular production of NO in cells, 4,5-
Diaminofluorescein Diacetate (DAF-2 DA), can be used for real-time bioimaging 



























Figure 2.5. Didox inhibition of NO production  in LPS-induced Raw 264.7 murine 
macrophages.  Raw 264.7 murine macrophages were incubated with or without Didox 
(6.25-200µM) and LPS (0.1µg/ml) for 24h and NO production quantified using the Griess 
reaction with sodium nitrite standard. Each value represents the mean ± SD of three 
experiments performed in triplicates. (*) indicates p<0.05 vs. the LPS-treated control group 




of NO with fine temporal and spatial resolution. Cells were treated with Didox or 
LPS and then loaded with the membrane-permeable DAF-2 DA which is 
subsequently hydrolyzed by cytosolic esterases releasing free DAF-2 DA that 
does not leak into the medium. At physiological pH, the DAF-2 is relatively non-
fluorescent, however, in the presence of NO and oxygen, DAF-2 triazole (DAF-
2T), a fluorescent product, is formed. The fluorescent images showed that 
treatment of cells with LPS produced more DAF-2 fluorescence compared to 
control and Didox addition inhibited LPS-induced fluorescence or NO production 
in Raw 264.7 cells (Fig 2.6 & Fig 2.6b). 
 
Dose-dependent reduction of LPS-induced IL-6 production in Raw 264.7 
murine macrophages by Didox.  
Interleukin-6 is one of the major inflammatory cytokines produced and secreted 
by LPS-activated macrophages. A sandwich ELISA assay was employed to 
measure the effect of Didox on IL-6 secretion in Raw 264.7 murine macrophage 
cells since Didox inhibitory effect was observed on IL-6 mRNA expression using 
RT-PCR. Cells were incubated with LPS (0.1 µg/ml) or Didox (0, 6.25, 12.5, 25, 
50, 100, and 200 µM) and culture medium harvested after 24h and analysed for 
IL-6 production using Mouse IL-6 ELISA Ready-SET-Go! Kit. Didox significantly 
decreased IL-6 production in a dose-dependent fashion (p<0.01) as compared to 
the LPS-stimulated cells. Didox at 100 µM reduced IL-6 production ten-fold after 
24 h (Fig 2.7). The B9 bioassay for IL-6 production also confirmed that Didox 









Figure 2.6. Assessment of intracellular NO production using DAF-2 DA 
detection system in Raw 264.6 cells treated with LPS in the presence or 
absence of Didox. Cells were seeded on cover slips at 2 x105 cell/well (in 6-well 
plates) for 3hrs. After loading cells with 10 µM DAF-2 DA for 15min, cells were 
treated with Didox (100µM) or LPS (1µg/ml). DAF-2T product fluoresces green 
upon reaction with NO. Cells were fixed and mounted on slides and analyzed using 






Figure 2.6b. Quantitative assessment of intracellular NO production using DAF-2 
DA detection system in Raw 264.6 cells treated with LPS in the presence or 
absence of Didox. Cells were seeded on cover slips at 2 x105 cell/well (in 6-well plates) 
for 3hrs. After loading cells with 10 µM DAF-2 DA for 15min, cells were treated with 
Didox (100µM) or LPS (1µg/ml). DAF-2T product fluoresces green upon reaction with 
NO. Cells were imaged using Nikon AZ100 Epi-Fluorescent Microscope under 488nm 
fluorescence wavelength, DIC-high, and the two were overlayed using the NIS-Elements 
Viewer 3.0. Mean fluorescence intensities were measured in various fields in triplicates 
and treatment effects were analysed using the paired t-test and p<0.05 (*) was 
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Figure 2.7. Didox inhibits IL-6 production in LPS-stimulated Raw 264.7 murine 
macrophages.  Raw 264.7 murine macrophages were incubated with Didox (0-200µM) 
and LPS (0.1µg/ml) for 24h and IL-6 production was measured from collected 
supernatants using the ELISA Ready-SET-Go Kit. Each value represents the mean ± 
SD of three experiments performed in triplicates. (*) indicates p<0.05 vs. the LPS-
treated control group not treated with Didox. 
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Figure 2.7b. Bioassay for IL-6 using the B9 cell line confirms that Didox inhibits 
IL-6 production in LPS-stimulated Raw 264.7 murine macrophages.  Raw 264.7 
murine macrophages were incubated with Didox (100µM) and LPS (0.1µg/ml) for 24h 
and collected supernatants diluted 1:5 were used to treat WEHI cells for 24h . Cell 
viability was detected using the MTT assay and the stimulation index was determined 
by dividing OD570nm (sample) with OD570nm (Control). After pelleting cells in the 96-well 




Didox and LPS treated Raw cells were used for treatment of WEHI cells, 
supernatants from DX treated cells resulted in minimal B9 growth compared to 
LPS counterparts. Supernatants from Raw cells treated with combination of DX 
and LPS resulted in lower B9 growth stimulation than those from LPS-treated 
cells(Fig 2.7b).  
 
Didox inhibits H2O2 production in Raw 264.7 murine macrophages treated 
with BSO, PMA, LPS or their combinations.  
During inflammatory reactions, activated macrophages produce H2O2 in large 
amounts. Catalase is a major antioxidant enzyme catalyzing the decomposition 
of hydrogen peroxide (H2O2 ) and its mRNA levels were upregulated by Didox as 
shown using RT-PCR. H2O2 production in Raw 264.7 cells was therefore 
determined using H2DCFA (2’,7’-dichlorodihydrofluorescein diacetate) assay after 
treatment with Didox (100µM), buthionine sulfoxamine, BSO (400µM) in the 
presence or absence of LPS (0.1µg/ml). H2DCFA is a cell-permeant fluorogenic 
indicator for reactive oxygen species (mainly H2O2) that is non-fluorescent until 
the acetate groups are removed by intracellular esterases and oxidation occurs 
within the cell in the presence of H2O2. Higher intracellular fluorescence was 
observed in BSO and LPS or PMA-treated cells compared to untreated controls. 
Didox (100 µM) inhibited H2O2 production in both BSO and LPS or PMA-treated 
cells as indicated by low intracellular DCFA fluorescence compared to BSO and 
LPS-treated cells (Fig 2.8A and 2.8B). Mean fluorescence intensities were 
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quantified using the Nikon NIS-Elements Viewer software and confirmed higher 
mean fluorescence intensities in BSO and LPS or PMA-treated cells compared to 



















Figure 2.8. Didox inhibits ROS generation in BSO and LPS-stimulated Raw 264.7 
murine macrophages. Cells were seeded at 5 x 10 5 cells/well in eight chamber cell 
culture slides for 3h and then treated with Didox (100µM), in the presence or absence of 
LPS (1µg/ml) [A], BSO (400µM) [B] or combination. After 24h incubation, H2DCFA 
solution was added to all wells and incubated for an additional 30 min at 37˚C.  Cells 
were imaged using Nikon AZ100 Epi-Fluorescent Microscope under 488nm fluorescence 
wavelength, DIC-high, and the two were overlayed using the NIS-Elements Viewer 3.0. 
Mean fluorescence intensities were measured [C] in various fields in triplicates and 
treatment effects were analysed using the paired t-test and p<0.05 (*) was considered to 





Didox inhibits production of superoxide radicals by LPS- and PMA- 
activated RAW 264.7 macrophages 
Since RT-PCR analysis showed an up-regulation of SOD in Raw 264.7 cells 
treated with Didox it was important to assess the intracellular levels of 
superoxides in these cells after treatment with Didox. To achieve this, cells were 
treated with Didox in presence or absence of LPS for 24h and then loaded with 
DHE for 2h in presence or absence of PMA. DHE-positive cells fluoresce red 
while unoxidized DHE remains blue. DHE-positive cells were assessed using a 
fluorescent microscope and superoxide production was quantified by measuring 
fluorescence intensity. Treatment of Raw 264.7 cells with LPS and PMA resulted 
in robust intracellular O2
● production whereas addition of Didox significantly 
decreased O2




Figure 2.9. Didox inhibits production of superoxide radicals by LPS-activated 
RAW 264.7 macrophages. Cells were treated with Didox in presence or absence of 
LPS for 24h on glass coverslips and then loaded with DHE for 2h. DHE-positive cells 







Figure 2.10. Didox inhibits production of superoxide radicals by PMA-activated 
RAW 264.7 macrophages. Cells were treated with Didox or PMA in presence or 
absence of BSO for 24h on glass coverslips and then loaded with DHE for 2h. DHE-












Figure 2.10b. Quantitave analysis of production of superoxide radicals by LPS-
activated RAW 264.7 macrophages after treatment with Didox. Cells were treated 
with Didox, LPS or PMA in presence or absence of BSO for 24h on glass coverslips and 
then loaded with DHE for 2h. DHE-positive cells fluoresce red and localize mostly in the 
nucleus while unoxidized DHE remains blue. Mean fluorescence intensities were 
measured in various fields in triplicates and treatment effects were analysed using the 
paired t-test and p<0.05 (*) was considered to be statistically significant. 
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Inhibition of LPS-mediated NF-κB(p65) nuclear translocation in Raw 264.7 
murine macrophages by Didox.  
The production of most inflammatory proteins is regulated through the NF-κB 
pathway and the RT-PCR mRNA expression assay showed that Didox has an 
effect on NF-κB expression. To define the molecular action by which Didox 
affects NF-κB activation pathway in Raw 264.7 murine macrophages, the cells 
were incubated with Didox (100 µM), LPS (0.1 µg/ml) or both for 24h and NF-κB 
(p65) levels. NF-κB translocation was evaluated using immunofluorescence 
microscopy by observing presence of p65 in cytosol or nuclei. More fluorescence 
was observed in the cytosol than in nuclei of untreated and Didox treated Raw 
264.7 murine macrophages whereas the reverse was observed in LPS-treated 
cells (Fig 2.11). Didox also reduced p65 presence in nuclei since less 
fluorescence was observed in nuclei of LPS-stimulated cells treated with 100 µM 
Didox while more fluorescence occurred in the cytosol. The presence of more 
p65 in cytosol of LPS-treated cells indicated that Didox inhibited translocation of 
LPS-induced NF-κB nuclear translocation.  
These results were confirmed using Western blot analysis which showed high 
presence of p65 protein levels in LPS-treated cells than in Didox-treated cells 
(Fig 2.12). The presence of high p65 protein levels in nuclei of cells stimulated 
with LPS was diminished by co-treatment with 100 µM Didox indicating the 
















Figure 2.11. Didox inhibits LPS-mediated NF-κB (p65) nuclear translocation in Raw 
264.7 cells. Cells were incubated with LPS (0.1µg/ml) and/or Didox (100µM) for 24h and 
NF-κB translocation was evaluated using immunofluorescence microscopy by observing 
presence of p65 in cytosol or nuclei using FITC-labeled Ab. Cells were imaged using Nikon 
AZ100 Epi-Fluorescent Microscope under FITC wavelength and mean fluorescence 
intensities were measured in various fields in triplicates and treatment effects were 
analysed using the paired t-test and p<0.05 (*) was considered to be statistically significant 
compared to controls(unless otherwise indicated) . See complete image below in Fig 2.11b 







Figure 2.11b. Complete view of  NF-κB nuclear translocation immunofluorescence 
in LPS-activated Raw 264.7 cells treated with Didox. The figure shows DAPI, DIC, 











Figure 2.12. Didox inhibits LPS-mediated NF-κB (p65) nuclear translocation in Raw 
264.7 cells. Cells were incubated with LPS (0.1µg/ml) and/or Didox (100µM) for 24h and 
NF-κB translocation was evaluated using western blot analysis after extraction of 
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Didox inhibits LPS-mediated protein expression of iNOS, Cox-2 and TNF-α 
in Raw 264.7 cells. 
Among the target inflammatory genes regulated by NF-κB activation, iNOS, Cox-
2, and TNF-α are central to onset and progression of macrophage-mediated 
inflammation. It was therefore essential to determine if Didox’s ability to inhibit 
NF-κB activation can influence protein expression levels of iNOS, Cox-2 and 
TNF-α. To achieve this goal Raw 264.7 macrophage protein expression levels of 
iNOS, Cox-2 and TNF-α were evaluated using the Western blot analysis after 24 
h of treatment with Didox (100 µM) in the presence or absence of LPS. Didox 
suppressed LPS-mediated protein expression of iNOS, Cox-2 and TNF-α in Raw 
264.7 macrophages after 24h (Fig 2.13). Supernatants from LPS-treated Raw 
cells were very toxic to WEHI cells during the WEHI bioassay for TNF-α 
production. Didox lowered this toxicity resulting in more WEHI survival since 
supernatants from Didox-treated Raw cells showed a higher WEHI cell survival 
compared to those from LPS-treated cells (Fig 2.13b). 
 
Didox suppresses phagocytosis on FITC-labeled latex beads by LPS and 
PMA activated Raw 264.7 murine macrophages 
To evaluate the effect of Didox on macrophage functionality, cells were incubated 
with FITC-labeled beads after treatment with Didox in the presence or absence of 
LPS or PMA as outlined above. Efficiency of phagocytosis was determined by 
using the phagocytosis index calculated as described above. Engulfment of 
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beads increased with LPS priming while cells treated with Didox engulfed fewer 
beads than untreated controls. Didox also reduced engulfment of FITC-labeled 
latex beads in LPS- and PMA-treated Raw 264.7 as fewer latex beads were 












Figure 2.13. Didox inhibits LPS-mediated protein expression of iNOS, Cox-2 and 
TNF-α in Raw 264.7 cells. Cells were incubated with LPS (0.1µg/ml) and/or Didox 
(100µM) for 24h and iNOS, Cox-2, and TNF-α protein expressions were evaluated using 
western blot analysis using β-actin house keeping gene to equalize loading.  
Control            DX           LPS       DX+LPS 
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Figure 2.13b. WEHI bioassay for TNF-α production confirms that Didox inhibits 
LPS-mediated production of bioactive TNF-α in Raw 264.7 cells. Raw cells were 
incubated with LPS (0.1µg/ml) and/or Didox (100µM) for 24h and supernatants were 
collected for use (1:5 dilution) in treating WEHI cells for 24h. Cell survival was 




















Figure 2.14. Didox inhibits uptake of FITC-latex beads in LPS-stimulated Raw 264.7 
cells. Cells were treated with Didox (100µM) or LPS (0.1µg/ml) and combination of both 
for 1h. FITC-labeled beads were added to each well and bead-uptake was evaluated 
using immunofluorescence  microscopy and images were analyzed using Nikon AZ100 
Epi-Fluorescent Microscope under FITC wavelength, DAPI wavelength, DIC-High and the 
three were overlayed using the NIS-Elements Viewer 3.0 (Fig 2.14b below shows the 




Figure 2.14b. Complete view of FITC-labeled beads in Raw 264.7 cells using DAPI, DIC, 
FITC channels, and their merged images. 
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The effect of Didox on filamentous actin (F-actin) polymerization and 
uptake of TRITC-labeled yeasts by Raw 264.7 murine macrophages. 
Uptake and killing of microorganisms by professional phagocytes are dependent 
on local, rapid remodeling of actin and immediately after ingestion phagosomes 
are surrounded by a distinct rim of filamentous actin (F-actin). To evaluate the 
Didox on this F-actin reorganization phenomenon and its role in phagocytosis, 
cells were challenged with TRITC-labeled yeasts (S. cerevisiae) with concomitant 
staining of F-actin using FITC-labeled phalloidin.  Cells were then fixed and 
analyzed using epi-fluorescent and confocal microscope.  Although untreated 
Raw macrophages engulfed more yeast cells, addition of Didox to untreated and 
LPS-treated cells resulted with a significant decrease in yeast-uptake (Fig 2.15). 
Staining of F-actin revealed that the actin cytoskeletal reorganization was robust 
and extensive without Didox treatment and a rim of F-actin located around the 
engulfed yeast particles. Although more extensions and striated villi were 
observed in the absence of Didox than when Didox was added, the actin 




Figure 2.15. Didox inhibits uptake of TRITC-labeled yeasts by Raw 264.7 
macrophages. Cells were seeded on coverslips in 6-well plates and incubated with 






The use of non-steroidal anti-inflammatory drugs that possess intrinsic anti-
inflammatory and antioxidant properties while triggering the intracellular 
cascades of protective pathways offers a promising strategy for therapeutic 
applications in macrophage-mediated aberrant inflammation. An interesting 
agent that might fulfill these criteria and inhibit excessive oxidative stress in 
macrophages is the polyhydroxyphenyl hydroxamic acid derivative, Didox (N-3,4-
trihydroxybenzamide), which has been shown to possess antioxidant, oxygen 
scavenging, and anti-inflammatory properties in a variety of experimental 
systems. As a result, studies to explore the anti-inflammatory effects of Didox on 
LPS-induced oxidative stress and inflammation in Raw 264.7 murine 
macrophages were a central focus area of this study. Didox comprise a new 
class of antioxidants with ability to inhibit ribonucleotide reductase activity, act as 
chelators of iron, and scavenge free radicals (Ding et al., 1992; Elford and Riet, 
1989).  
 
Didox was also previously shown to inhibit a preeminent inflammatory 
transcription factor, NF-κB, probably due to their selective inhibition of 
phosphorylation of the cytoplasmic inhibitor IκBα (Lee et al., 1997). Whether this 
interesting molecule has other molecular effects that are potentially therapeutic is 
unknown. It was therefore important to study the anti-inflammatory effect of Didox 
in the LPS-stimulated Raw 264.7 murine macrophages and propose the 
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molecular mechanism that could be involved in governing the resulting immuno-
modulatory effects. 
 
The evaluation of Didox’s potential anti-inflammatory effects was carried-out 
using the LPS-inducible Raw 246.7 murine macrophage model system. The Raw 
264.7 murine macrophage cell line is most suitable for these studies because of 
its morphological and functional similarity to human macrophage system. This 
cell line is sensitive to LPS derived from gram-negative bacteria and thus 
provides an inducible form of macrophages that undergo phagocytosis and 
secrete lysozyme upon activation. This allows the evaluation of Didox on gene 
profiles, morphological outlines, functional characteristics and inflammatory 
behavior of macrophages in the activated and non-activated forms.  
 
The first undertaking was to evaluate the cytotoxic effect of Didox on Raw 264.7 
macrophages and find an optimal concentration of Didox suitable for modulating 
the inflammatory behavior of Raw 264.7 murine macrophages. This was done by 
subjecting Raw cells to increasing concentrations of Didox for 24h and 
determining the cells’ viability profiles.   The MTT assay revealed that Didox 
doses up to 100µM do not cause any significant reduction in cell death of Raw 
264.7 macrophages and this was further confirmed by using the PI dye exclusion 
assay and Flow cytometry assay using PI and Annexin-V.  Together these set of 
results show that both LPS (0.1µg/ml) and Didox (100µM) do not significantly 
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inhibit cell proliferation or induce any form of cell death in Raw 264.7 murine 
macrophages during 24h of treatment. Didox is known for its inhibitory role on 
ribonucleotide reductase, an enzyme that catalyses the reduction of all four 
ribonucleotides to deoxyribonucleotides for use in DNA synthesis. This RR 
inhibitory property of Didox warrants an investigation into the potential cytostatic 
action of this drug on Raw 264.7 cells. Differential interference contrast (DIC) 
microscopic images were taken at 12h intervals for up to 48h to evaluate cell 
growth profiles and colony formation after treating cells with LPS, Didox or in 
combination. The cell growth profiles were not significantly affected by Didox or 
LPS during the 48h period, suggesting that Didox does not exert a significantly 
noticeable cytostatic action on these Raw cells.   
 
There is a wide variety of genes and pathways that play a pivotal role in 
regulation or generation of oxidative stress in activated macrophages; hence it 
was therefore necessary to start by identifying the effect of Didox on expression 
of genes associated with inflammation and oxidative stress in LPS-activated Raw 
264.7 macrophages.  This was achieved through a multi-gene profiler array 
system that assayed a total of more than 200 genes involved in Raw 264.7 
inflammatory behavior. These PCR arrays are the most reliable tools for 
analyzing the expression of a focused panel of genes with high reproducibility, 
sensitivity and specificity. Raw 264.7 cells were treated with LPS, Didox, or 
combination of both for 24h and mRNA isolated for gene expression studies and 
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several oxidative stress and inflammation-related genes significantly affected by 
Didox were indentified. Multigene profiling with real time PCR Array Profiler 
revealed Didox-mediated inhibition of several inflammatory genes involved in 
LPS-induced macrophage inflammatory activities and these included chemokines 
(CCL2, CCL3, CCL4, CXCL10), IL-1, IL-6, TNF-α, iNOS, NADPH oxidase, GM-
CSF (Csf2), G-CSF (Csf3), Akt1, NF-κB (p105), and TLR4. Didox treatment also 
resulted in increased mRNA gene expression of catalase, glutathione 
peroxidase, and superoxide dismutase as determined by multigene superray 
profiler. Once the effect of Didox on these genes was noticed, it was therefore 
required to carry-out a PCR validation assay using specific primers targeting the 
selected genes. The PCR validation assay confirmed that Didox suppressed 
mRNA expression of IL-6, TNF-α, iNOS, Cox-2, p38α, p65, and p21.  
 
Taking a closer look at these Didox-suppressed gene: TNF-α is known to be a 
key mediator for the induction of apoptosis and development of humoral immune 
response. However, at high concentrations, TNF-α has more pronounced 
disadvantageous effects, such as inducing tissue injury, oxidative stress, 
inflammation and potentiating septic shock (Shohami et al., 1999). Elevated 
serum IL-6 levels have been observed in a number of pathological conditions, 
including bacterial and viral infections, trauma, autoimmune diseases, and 
inflammations (Hirano et al., 1994). iNOS catalyses the formation of NO, a highly 
reactive free radical involved in a number of physiological and pathological 
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processes.The role of NO is well established in the relaxation of vascular smooth 
muscles, in the inhibition of mitogenesis and growth of glomerular mesangial 
cells, and in macrophage toxicity. Under normal physiological conditions NO also 
acts immunologically as a cytotoxic agent on invading microorganisms in 
macrophages or on tumor cells. Oxidative stress and inflammatory responses in 
activated Raw 264.7 cell line have been linked to increase in mRNA expressions 
of inflammation-related genes such as IL-1, IL-6, TNF-α, iNOS, and COX-2 
induced via the NF-κB pathway (Park and Park, 2009). Thus, it is well 
documented that these above-mentioned Didox-suppressed genes play a pivotal 
role in induction of cellular oxidative stress and inflammation in macrophages and 
their inhibition opens possibilities for Didox as a regulator of oxidative stress and 
inflammation.   
 
IL-6 has often been linked to inflammatory as well as autoimmune diseases and 
influences a plethora of cellular functions. IL-6 has also been well demonstrated 
to be among the strong mediators of oxidative stress and has the potential to 
alter redox equilibrium (Nussler et al., 1992, Chen et al., 1998, Desmarquest et 
al., 1998). This prompted us to investigate the effect of Didox on production of IL-
6 in LPS-activated Raw 264.7 murine macrophages. Treatment of cells with 
Didox led to a dose-dependent reduction of IL-6 secretion by LPS-stimulated 
macrophages with maximal inhibition attained at 100 µM concentration of Didox. 
These results correlated with the real-time PCR evaluation assays which showed 
that Didox reduced LPS-mediated mRNA expression of IL-6. Didox could, 
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therefore, be exerting its inhibitory effects on ROS generation via inhibition of IL-
6 production thereby reducing the LPS-induced inflammatory activity of Raw 
264.7 murine macrophage cell lines. 
 
Results from RT-PCR validation assays also confirmed that Didox-mediated 
inhibition of inflammatory genes in LPS-activated Raw 264.7 macrophages was 
accompanied by up-regulation of antioxidant enzymes: catalase (Cat), 
glutathione peroxidase (Gpx), and superoxide dismutase (SOD). Since oxidative 
stress is a result of a perturbed balance between ROS production and 
antioxidant levels, the up-regulation of antioxidant pools with concomitant 
inhibition of oxidative stress genes is very important in shifting the oxidative 
stress status to the homeostatic stage.   
 
Inhibition of iNOS mRNA expression warranted an investigation on iNOS activity 
by determining if Didox inhibits NO secretion in LPS-stimulated Raw 264.7 
murine macrophage cell line. Using the Griess assay it was shown that Didox 
dose-dependently inhibits LPS-induced NO secretion. To further determine 
intracellular NO production, a vital dye sensitive for NO was used to track NO 
levels after treatment of LPS-activated Raw cells with Didox. DAF-2DA 
fluorescence was robust in LPS-treated cells compared to untreated controls and 
this NO sensitive fluorescence was ablated with addition of Didox, confirming the 
ability of Didox to suppress intracellular NO production.  
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Other ROS and RNS mediators that induced oxidative stress include H2O2, 
superoxide radicals, and nitrogen peroxides. Evaluation of intracellular ROS 
production using a fluorescein marker indicated that H2O2 increased with addition 
of buthionine sulfoximine (BSO) or LPS. LPS induces its inflammatory actions in 
macrophages via TLR4 while BSO is an inhibitor of the glutamatecysteinyl ligase 
(GCL) enzyme and thus may exhibit a "pro-oxidative" action by depleting 
glutathione pools. Didox inhibited both BSO and LPS-mediated intracellular H2O2 
production and this was demonstrated via reduction of dichlorofluorescein (DCF) 
fluorescence in Didox-treated Raw 264.7 cells. Accumulation of DCF indicates 
the production of H2O2, a redox-active molecule (Bass et al., 1983, Royall and 
Ischiropoulos, 1993). Reduction of fluorescence therefore suggests that Didox 
inhibits H2O2 generation, an event that directly correlates with upregulation of 
catalase mRNA expression and could suggest that Didox reduces H2O2 levels 
either by upregulating catalase gene expression or activity.  Didox upregulates 
Gpx mRNA levels in Raw 264.7 cells and Gpx could also be responsible for 
reduced H2O2 levels as it also catalyses the  scavenging and decomposition of 
H2O2 in these cells. 
 
Since SOD mRNA levels were upregulated in Didox-treated Raw 264.7 cells and 
SOD dismantles superoxide (O2
●) radicals, it was necessary to assess the 
production of intracellular O2
● levels in LPS-activated Raw cells after treatment 
with Didox.  Superoxide produced in cells was measured using the cell-
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permeable dye dihydroethidium (DHE), which mostly binds to nuclear DNA when 
oxidized by superoxide and emits red fluorescence whereas the unoxidized DHE 
emits blue fluorescence and remains localized mostly in the cytoplasm. DHE has 
been specifically recommended for assessments of superoxide production in 
cells because of its relatively high specificity (Zhao et al., 2003). A vigorous red 
fluorescence was observed in LPS-treated Raw cells while Didox treatment 
significantly reduced the red fluorescence during 24h incubation.  Further 
addition of BSO, which depletes the GSH pools, exacerbated and increased 
superoxide mediated fluorescence especially when this was combined with LPS 
treatment of Raw cells. Didox rescued both BSO and LPS induced superoxide 
production as shown by the resulting diminished red fluorescence post-treatment. 
Potential implications of this reduction in intracellular detection and imaging of 
superoxide by Didox in activated Raw cells is of significant importance since 
superoxide radicals represent a highly reactive and cytotoxic group of free 
radicals contributing to the generation of oxidative stress in inflammatory 
diseases. 
 
Several lines of evidence have revealed a requirement of ROS generation in NF-
κB activation and suggest that ROS production leads to site-directed NF-κB 
oxidation resulting in increased NF-κB activation (Jaramillo et al., 2005, Jaramillo 
and Olivier, 2002). Previous studies have also demonstrated that certain 
antioxidants may block translocation of activated NF-κB complexes from the 
cytoplasm to the nucleus, thus inhibiting NF-κB mediated gene activation (Bowie 
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et al., 1997).  LPS-stimulation of Raw cells leads to phosphorylation of NF-κB 
dimers (p65/p50) in the cytoplasm. Upon phosporylation, the p65/p50 dimer 
translocates from the cytoplasm to the nucleus and activates expression of target 
inflammatory genes (including IL-6, TNF-α, iNOS, Cox-2) by binding to specific 
promoter consensus sequences. We hypothesized that Didox-mediated inhibition 
of LPS-induced inflammation in Raw 264.7 murine macrophages may be effected 
via modifications on NF-κB activity or function. In order to test this hypothesis, we 
examined nuclear localization of NF-κB complexes in Raw 264.7 murine 
macrophages after LPS or Didox treatment using immunofluorescence 
microscopy.  
 
LPS stimulation of Raw 264.7 murine macrophages resulted in prompt 
translocation of p65 from the cytoplasm to the nucleus. However, Didox 
treatment counteracted this LPS-mediated p65 translocation since more p65 was 
observed to be present mostly in the cytoplasm than in the nucleus of these 
macrophages. The Didox-mediated inhibition of NF-κB translocation was 
confirmed using a Western blot analysis which revealed higher p65 protein levels 
in the nucleus after LPS-stimulation of Raw cells, whereas addition of Didox 
lowered this LPS-induced nuclear p65 protein expression. This inhibition of NF-
κB nuclear translocation suggests an ability of Didox to suppress oxidative stress 
induction in Raw 264.7 murine macrophages by inhibiting the NF-κB pathway. 
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To determine the effect of Didox on Raw 264.7 murine macrophage functionality 
a phagocytosis assay was carried out using FITC-labeled latex beads and 
TRITC-labeled yeasts. To achieve this, we incubated Raw macrophages with 
FITC-labeled latex beads in the presence of either LPS or Didox or both and 
assessed the uptake of beads using immunofluorescence microscopy. Non-
engulfed excess FITC-beads were washed and quenched with trypan blue to 
ensure that the fluorescence observed only reflects those beads internalized by 
macrophages. Most beads were internalized my macrophages after stimulation 
with LPS alone but addition of Didox reduced this LPS-mediated bead uptake. 
Although staining of F-actin in Raw 264.7 cells revealed that the actin 
cytoskeletal reorganization was robust and extensive with LPS treatment and 
vigorous extensions and nodules were observed in the absence of Didox than 
when Didox was added, the influence of Didox on the actin cytoskeleton was not 
strong enough to qualify it as a significant inhibition. There could be other 
signaling events involved in the reorganization of F-actin since the effect of Didox 




In summary, we found that Didox inhibited LPS-induced oxidative stress, ROS 
generation, IL-6 production, NO production, phagocytic activity, and NF-κB 
nuclear translocation in Raw 264.7 murine macrophages. Due to its antioxidant 
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characteristics, Didox might be used to prevent ROS-induced inflammatory 
diseases such as sepsis-related injuries, cancer, fibrosis, emphysema, and 
arthritis. More studies are needed to demonstrate its mechanism of action and 
potential benefits in humans, however. Other studies done with clinical trials on 
patients with advanced breast cancer treated with Didox at 6 g m-2 given by 
intravenous infusion over 36 h every 3 weeks demonstrated minimal toxicity with 
high drug clearance (Carmichael et al., 1990, Rubens et al., 1991). This shows 
that Didox administration can be tolerated by patients with minimal side effects 
and once its use in inflammation-based diseases is delineated, its application in 













DIDOX MODULATES AHR LIGAND-INDUCED OXIDATIVE 
STRESS, CYP1A1 INDUCTION, AND AHR-ACTIVITY IN RAW 
264.7 MURINE MACROPHAGES. 
 
ABSTRACT 
Aryl hydrocarbon receptor (AHR) activation has been shown to induce oxidative 
stress, various transcription factors, and subsequent inflammatory processes 
mediating toxic and carcinogenic effects in vascular endothelial cells. Didox(3,4-
Dihydroxybenzohydroxamine) is a powerful synthetic antioxidant  and one of the 
most potent ribonucleotide reductase (RR) inhibitors, revealing an antitumor 
effect in several experimental studies. To test the hypothesis that Didox can 
modify AHR-mediated oxidative stress, Raw 264.7 murine macrophage cells 
were treated with AHR ligands (PCB126, E804, IO) with or without Didox for 24h. 
Didox strongly inhibited oxidative stress induced by PCB126 as measured by 
DCF fluorescence.  
 
The role of cytochrome P450 1A1 (CYP1A1) in the AHR ligand-induced toxicity 
was investigated. Didox at 100 µM concentrations markedly inhibited CYP1A1 
and AHR mRNA levels. Using immunofluorescence microscopy, Didox was 
shown to significantly inhibit both AHR nuclear translocation and CYP1A1 
expression in Raw 264.7 cells treated with these AHR ligands.  Furthermore, 
Didox downregulated reactive oxygen species production induced by PCB126, 
E804, and IO in Raw 264.7 murine macrophages. These data suggest that 
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oxidative stress regulatory effects of Didox may be useful in managing 
inflammatory diseases initiated by exposure to AHR activating xenobiotics. 
 
INTRODUCTION 
Exposure to toxic polycyclic aromatic hydrocarbons produces oxidative stress 
and raises a number of toxic and carcinogenic responses in experimental 
animals and humans mediated for the most part by the aryl hydrocarbon – or 
dioxin – receptor (AHR) (Meijer et al., 2007). The AHR is a ligand-activated 
transcription factor whose central role in the induction of drug-metabolizing 
enzymes has long been recognized. For quite some time now, it has become 
clear that the AHR also functions in pathways outside of its role in detoxification 
and that perturbation of these pathways by xenobiotic ligands may be an 
important part of the toxicity of these compounds. The aryl hydrocarbon (dioxin) 
receptor (AHR) is a cytosolic ligand-activated transcription factor that mediates 
many toxic and carcinogenic effects in animals and possibly in humans (Barouki 
et al., 2007).  
 
It is generally accepted that its activation in vertebrates causes the toxic and 
carcinogenic effects of a wide variety of environmental contaminants such as 
dioxin (TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin), coplanar polychlorinated 
biphenyls (PCBs) and polycyclic or halogenated aromatic hydrocarbons (PAHs or 
HAHs). As a consequence of AHR activation, many detoxification genes are 
transcriptionally induced, including those coding for the Phase I xenobiotic-
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metabolizing cytochrome P450 enzymes CYP1A1, CYP1A2, CYP1B1, and 
CYP2S1, and the phase II enzymes UDP-glucuronosyl transferase UGT1A6, 
NAD(P)H-dependent quinone oxydoreductase-1 NQO1, the aldehyde 
dehydrogenase ALDH3A1, and several glutathione-S-transferases (Barouki et 
al., 2007).  
 
AHR is a member of the bHLH/PAS family of heterodimeric transcriptional 
regulators (basic-region helix-loop-helix/Period [PER]-Aryl hydrocarbon receptor 
nuclear translocator [ARNT]-single minded [SIM]) (Hoffman et al., 1991) involved 
in regulation of development and in control of circadian rhythm, neurogenesis, 
metabolism and stress response to hypoxia. Evidence from AHR knockout mice, 
however, points to functions of the receptor beyond xenobiotic metabolism at 
several physiologic roles that may contribute to the toxic response. Ablation of 
the Ahr gene in mice leads to cardiovascular disease, hepatic fibrosis, reduced 
liver size, spleen T-cell deficiency, dermal fibrosis, liver retinoid accumulation and 
shortening of life span (reviewed in Barouki et al., 2007), suggesting that it has 
biological functions other than xenobiotic detoxification that likely contribute to 
the overall toxic response resulting from its activation.  
 
The AHR is widely expressed in practically all mouse tissues (Abbott et al., 
1995), and in humans expression is high in lung, thymus, kidney and liver. In the 
absence of ligand, the AHR exists as part of a cytosolic protein complex 
containing two HSP90 chaperone molecules, the HSP90-interacting protein p23 
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and the immunophilin-like protein XAP2  (Petrulis et al., 2003). Activation by 
ligand is followed by translocation of the complex into the nucleus, dissociation 
from the chaperone proteins and heterodimerization with ARNT. This AHR-ARNT 
heterodimer interacts with several histone acetyltransferases and chromatin 
remodeling factors and the resulting complex binds to consensus regulatory 
sequences termed AHREs (aryl hydrocarbon response elements; also XREs or 
DREs), located in the promoters of target genes, and by mechanisms not yet well 
characterized, recruits RNA polymerase II to initiate transcription. The activated 
AHR is quickly exported to the cytosol where it is degraded by the 26S 
proteasome (Pollenz, 2002), hence preventing constitutive receptor activity. 
 
Activation of the AHR by high-affinity HAH or PAH ligands results in a wide range 
of cell cycle perturbations, including G0/G1 and G2/M arrest, diminished capacity 
for DNA replication, and inhibition of cell proliferation. These alternative functions 
of the AHR are often accomplished in the absence of an exogenous ligand, but 
the underlying molecular mechanisms governing these processes remain elusive 
in part because no definitive endogenous ligands have been identified (reviewed 
in Puka et al., 2002). At present, all available evidence indicates that the AHR 
can trigger signal transduction pathways involved in proliferation, differentiation 
or apoptosis by mechanisms dependent on xenobiotic ligands or on endogenous 
activities that may be ligand mediated or completely ligand independent. These 
functions of the AHR coexist with its well-characterized toxicological functions 
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involving the induction of Phase I and Phase II genes for the detoxification of 
foreign compounds. 
 
Polychlorinated biphenyls (PCBs) are widespread persistent residual 
environmental contaminants and possess the ability to activate the AHR pathway 
via binding to AHR. Some of  the PCBs, e.g. 3,3’,4,4’,5-pentachlorinated 
biphenyls 126 (PCB126), have been demonstrated to produce extensive cellular 
oxidative stress in vertebrates, including rodents (Fadhel et al., 2002) and human 
hepatoma cells (Park et al., 1996). The antioxidant vitamin E has been shown to 
have a protective effect against the gross morphological changes induced by 
PCB126 exposure in zebrafish embryos (Na et al., 2009), indicating a potential 
use of similar antioxidants in relieving oxidative stress induced by PCBs. PCB-
126 has been also shown to potentiate enhancement of plasma lysozyme levels 
and increase Cyp1A1 induction in channel catfish, Ictalurus punctatus (Burton et 
al., 2002; Rice and Roszell, 1998). The co-planar structure of PCB 126 allows it 
to interact with AHR and activate subsequent AHR nuclear translocation.  
 
Other molecules discovered to posess ability to bind AHR include indirubin and 
indirubin-derivatives (Kawanishi et al., 2003). Indirubin derivatives such as 
Indirubin-3’-(2,3 dihydroxypropyl)-oximether (E804) have been demonstrated to 
block Stat3 signaling in human breast and prostate cancer cells via interactions 
with AHR. Studies on AHR activation using indirubin derivatives demonstrated 
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that although derivatives such as 6-Bromoindirubin-3’-monoxime (BIO) and 5-
Iodo-Indirubin-3’-monoxime (5-Iodo) bind to AHR and induce its nuclear 
translocation, they also triggered ARNT-independent nuclear redistribution of 
AHR (Knockaert et al., 2004). Indirubin-3-monoxime is an aryl hydrocarbon 
receptor (AHR)-binding, idole-derived compound known to be a potent inducer of 
CYP1A1, at least in hepatic cell lines and indirubin-3′-monoxime has been 
demonstrated to either act as classical AHR ligand, or modulates endogenous 
AhR-regulated activity in U937 histiocytic lymphoma cells (Springs and Rice, 
2006). 
 
 These results demonstrate that indirubins and indirubin derivatives are potent 
and functional ligands for AHR in living cells and that ARNT is not necessary for 
indirubin-induced nuclear translocation of AHR. The discovery of the interaction 
of indirubins with AHR opens the possibility that indirubins and indirubin 
derivatives prevent cell proliferation and induce cellular oxidative stress via the 
AHR pathway.  
 
The persistence and prevalence of various exogenous AHR ligands in 
environmental resources necessitates a search for molecules that can inhibit 
AHR-mediated oxidative stress in an attempt to ameliorate AHR-induced disease 
conditions outlined above.  Although an AHR-mediated oxidative stress response 
does not necessarily result in toxicity, it is a component in the mechanism of 
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many toxic events that generate high amounts of ROS and RNS which ultimately 
result in cellular stress, cell death or carcinogenesis. This is because AHR 
regulates the expression of phase I and phase II detoxification enzymes that, by 
the nature of their enzymatic activities, generate electrophilic reaction, which 
cause oxidative stress, and conjugation reactions which attempt to combat it. 
Therefore AHR activation results in a shift in the cellular redox balance, 
suggesting a diverse and sophisticated phenomenon in oxidative stress response 
and generation.  
 
Since Vitamin E has shown potential oxidative stress inhibition capacity in 
PCB126 induced AHR activation, similar antioxidants and NSAIDS such as Didox 
can be evaluated for their ability to curb AHR-mediated oxidative stress. The 
absence of endogenous ligands to AHR opens possibilities that AHR inhibitors 
may be able to associate with AHR in various ways since endogenous ligands 
may be using similar associations themselves.  Didox is presented here as such 
a potential AHR pathway inhibitor due to its well documented ability to scavenge 
free radicals, block production of inflammatory cytokines, and reduce oxidative 
stress in various experimental modules without inducing major side effects and 
cytotoxicity. Its structural outlook may not permit binding to AHR but its activity 
profiles may allow it to associate with AHR mediators and the AHR pathway in 




MATERIALS AND METHODS 
 
Materials 
Indirubin derivatives and PCBs were obtained as follows: IO or Indirubin-3’-
monoxime (A.G. Scientific Inc., San Diego, CA), E804 or Indirubin-3’-(2,3 
dihydroxypropyl) oximether (Alexis Biochemical, San Diego, CA), PCB126 or 
3,3’,4,4’,5-pentachlorobiphenyl (Ultra Scientific, North Kingston, RI), and PCB104 
or 2,4,6,2’,6’-pentachlorobiphenyl (Ultra Scientific, North Kingston, RI). Didox 
was provided by Dr. Howard Elford, Molecules for Health Inc. (Richmond, VA) 
and phorbol-12-mristate-13-acetate (PMA) was purchased from A.G. Scientific 
Inc., San Diego, CA. LPS from E. coli serotype R515(Re) (ultra pure, 
TLR4grade™) was purchased from Alexis biochemicals, San Diego, CA and FBS 
from Atlas biological, Fort Collins, CO. DMEM, FBS, HEPES, glucose, sodium 
bicarbonate, penicillin, streptomycin, paraformaldehyde, Triton X-100 , sodium 
borohydride, buthionine sulfoximine and dimethyl sulfoxide (DMSO Hybri Max®) 
were purchased from Sigma, St Louis, MO.  
 
H2DCFA, DHE, DAF-2 DA (Molecular Probes, Eugene, OR) , rabbit anti-AHR 
polyclonal antibody (Thermo Fisher Sci., Fremont, CA), goat-anti rabbit 
polocylonal Ab, Raw 264.7 murine macrophage cells (ATCC®, Manassas, VA) , 
RT2 Profiler™ PCR Array System, RT2 First Strand Kit and RT2 qPCR Master 
Mix were purchased from SABiosciences Corp., Frederick, MD, PCR primers  
from IDT®, Coralville, IA, TRI-reagent® from Molecular Research Center, 
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Inc.Cincinnati, OH and Halt™ Protease Inhibitor Cocktail from Thermo Fisher 
Sci., Rockford, IL. All other chemicals were purchased from Sigma, St Louis, MO.  
 
Cell Cultures 
Murine macrophage RAW 264.7 cells were cultured in Dulbecco’s modified 
Eagle’s medium (DMEM) containing 25 mM HEPES buffer, 3 g/L D-glucose, 1.5 
g/L sodium bicarbonate and 4 mM L-glutamine. The culture media were 
supplemented with 10% fetal bovine serum, penicillin (100 units/ml) and 
streptomycin (100 µg/ml). All cultures were maintained in a humidified incubator 
in 5% CO2 at 37 °C and cells were be split for sub-culturing two times a week. 
 
Treatment Preparations 
Didox (3,4-Dihydroxybenzohydroxamine) obtained was dissolved in dimethyl 
sulfoxide (DMSO Hybri Max®  purchased from Sigma, St Louis, MO)  to a final 
stock concentration of 200 mM and further diluted in culture medium to the 
working serially diluted concentrations ranging from 3.12 – 200 µM. LPS (E. coli, 
Serotype R515 ultra-pure, TLR4 gradeTM purchased from Alexis Biochemicals, 
San Diego, CA) was diluted in serum-free culture medium before adding to 
culture treatments. Indirubin derivatives and PCBs were also dissolved in DMSO 





Flow Cytometry ApoScreen™ Annexin V Apoptosis Assay 
Assessment of ability of AHR ligands, Didox or LPS to induced apoptosis in Raw 
cells was carried out using AnnexinV/PI double staining. Apoptosis was 
quantified by measurement of externalized phosphatidylserine residues as 
detected using ApoScreen™ Annexin V Apoptosis Kit (Southern Biotech, AL, 
USA). Raw 264.7 murine macrophages were seeded at 2.5 x 106 cells/well in 24-
well plates for 3hrs and treated with 10 µM of AHR ligands (PCB126, E804, IO) 
or non-AHR ligands (PCB104) with or without Didox (100µM) for 24hrs.  After 
treatment cells were washed with ice-cold PBS and 500 µl of Annexin V binding 
buffer. The binding buffer (100 µl) was replaced in all wells, 5 µl of Annexin V-
FITC was added, and the mixture was incubated for 15 min on ice with slow 
shaker in the dark. Without washing, 380 µL of cold 1X binding buffer and 10 uL 
of PI were added to each tube. After washing the samples, aliquots were 
processed by flow cytometer using FACScanTM (BD Biosciences, San Jose, CA) 
and 10,000 cells were scored in each event. 
 
Fluorescence Microscopy Analysis of Cell death using Hoescht/PI staining 
Cells were treated as indicated above on Lab-Tek® 8-chamber glass cultures 
slides (Nalge Nunc Int., IL, USA) or Corning glass cover slips and Hoescht/PI 
stain was added the cells for 15min. After washing off the dyes cells were 
mounted using 50% glycerol (in PBS) with colorless nail polish sealing and 
viewed under a fluorescent microscope. 
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Mouse Oxidative Stress Gene Analysis using RT2 ProfilerTM PCR-Arrays.  
To search for candidate genes modulated by Didox after treatment of Raw cells 
with PCB126, cells were seeded at 5 X 106 cells/ml in 75 cm2 culture flasks 
(Corning Inc., NY) and allowed to adhere to flask surfaces to 3h. Cells were then 
treated with PCB126 in the presence of absence of Didox (100 µM) and RNA 
was extracted from cells after 24h using TRI-reagent® from Molecular Research 
Center, Inc.(Cincinnati, OH) and retrotranscribed by RT-PCR first strant kit 
(SuperArray Bioscience Corporation, Frederick, MD). Real-time PCR was 
performed using the Mouse Oxidative Stress RT2 Profiler PCR Arrays and RT2 
Real-Timer SyBR Green/qPCR Master Mix from SuperArray Bioscience 
Corporation (Frederick, MD) on BioRad iQ5 real-time PCR detection system 
(Applied Biosystems). For data analysis the ∆∆Ct method was used; for each 
gene fold-changes were calculated as difference in gene expression between 
untreated controls and treated cell cultures. A positive value indicates gene up-
regulation and a negative value indicates gene down-regulation. 
 
AHR and Cyp1A1 Real-Time PCR assays 
To evaluate the effect of AHR ligands (PCB126, E804, IO) on AHR and Cyp1A1 
mRNA expression, RNA was extracted and cDNA obtained from treated murine 
macrophages as mentioned above. mRNA levels were analysed by using the 
following conditions: 1 cycle at 95°C for 10 min, 40 cycles at 95°C for 15 sec, 
55°C for 1 min and quantified using primers listed in Table 3.1 below. The 
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quantities of these mRNAs were expressed as fold-changes compared to the 
untreated Raw 264.7 murine macrophage controls. 
 
 
Table 3.1: Primer sequences used for RT-PCR validation of AHR and Cyp1A1 gene 
























Evaluation of AHR nuclear translocation using Immunofluorescence 
Microscopy. 
To assess AHR activity in Raw 264,7 murine macrophages, immunofluorescence 
microscopy was use to monitor translocation of AHR from cytosol to nucleus after 
potentially binding to AHR ligands. Raw 264.7 cells were cultured cells in 8-
chamber slides at 2 x105 cells/well and seeded for 3hrs followed by a 4h 
treatment with 10 µM of AHR ligands (PCB126, E804, IO) or non-AHR ligands 
(PCB104) with or without Didox (100µM). Cells were then fixed with 4% ρ-
formaldehyde for 1hr and permeablized with 0.1% Triton X-100/1%BSA in PBS 
for 30 min on a slow shaker. To quench out any residual fluorescence, cells were 
treated with 0.01% sodium borohydride (in PBS)  for 5 min and then incubated 
with 1% BSA for 30 min to block non-specific binding sites. Cells were then 
incubated for 1hr with rabbit anti-mouse AHR antibody followed by 1hr incubation 
with FITC-labeled goat anti-rabbit IgG. The nuclei were stained with DAPI 
addition for 5 minutes and cells were mounted on slides with coverslips using 
50% glycerol in PBS. After sealing the edges with nail polish slides were viewed 
under Nikon AZ100 epi-fluorescent microscope. 
 
Assessment of CYP1A1 induction in Raw 264.7 cells using 
Immunofluorescence Microscopy. 
To assess CYP1A1 in Raw 264.7 murine macrophages after treatment with AHR 
ligands, immunofluorescence microscopy was used.  Raw 264.7 cells were 
cultured cells on coverslips at 2 x105 cells/well in 6-well culture plates and 
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seeded for 3hrs followed by a 4h treatment with 10 µM of AHR ligands (PCB126, 
E804, IO) or non-AHR ligands (PCB104) with or without Didox (100µM). Cells 
were then fixed with 4% ρ-formaldehyde for 1hr and permeablized with 0.1% 
Triton X-100/1%BSA in PBS for 30 min on a slow shaker. To quench out any 
residual fluorescence, cells were treated with 0.01% sodium borohydride (in 
PBS)  for 5 min and then incubated with 1% BSA for 30 min to block non-specific 
binding sites. Cells were then incubated for 1hr with rabbit anti-mouse CYP1A1 
antibody followed by 1hr incubation with FITC-labeled goat anti-rabbit IgG. The 
nuclei were stained with DAPI addition for 5 minutes and cells were mounted on 
slides with coverslips using 50% glycerol in PBS. After sealing the edges with 
nail polish slides were viewed under Nikon AZ100 epi-fluorescent microscope. 
 
Evaluation of ROS production using fluorescent microscopy  
Cells were seeded at 5 x 105 cells/well in eight chamber cell culture slides for 3h 
and then treated with PCB126 (10 µM) in the presence or absence of Didox 
(100µM). After 24h incubation, H2DCFA solution was added at 10
-5 M to all wells 
and incubated for an additional 30 min at 37˚C. The slides were washed twice 
with PBS, fixed with 4% ρ-formaldehyde for 1hr and mounted using glycerol:PBS 
(1:1) solution. The cover slip was placed over the mounting medium and the 
slides were sealed using nail polish. The slides were viewed under the 
fluorescence microscope and images capture using the digital camera. 
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Assessment of intracellular superoxide radical production in Raw 264.7 
cells 
Superoxide production in Raw cells was assayed by using the oxidative 
fluorescent dye DHE. DHE is oxidized on reaction with superoxide to ethidium 
bromide, which mostly binds to DNA in the nucleus and fluoresces red. Cells 
were seeded on cover slips at 2 x105 cells/well (in 6-well plates) for 3hrs. To 
quench out any residual fluorescence, cells were treated with 0.01% sodium 
borohydride (in PBS) for 5 min. After loading cells with 10 µM DHE for 15min, 
cells were treated for 120 min with 1 µM of AHR ligands (PCB126, E804, IO) or 
non-AHR ligands (PCB104) with or without Didox (100µM). Cells were fixed and 
mounted on slides and analyzed using the Nikon AZ100 epi-fluorescent 
microscope. The un-oxidized DHE remains blue (λEx\Em =355\420nm) while the 
oxidized DHE fluoresces red (λEx\Em=355\420nm). Images were captured using 
the NIS-Elements Viewer 3.0. 
 
Statistical Analysis 
All experiments are representative of three repeats carried out in triplicates and 
the error bars represent the standard deviation from the mean average. All data 
representations were analyzed using Graphpad PRISM 4.0 (Graphpad, San 
Diego, CA, USA) or Sigmaplot (SPSS). Treatment effects were analysed using 






Flow Cytometry ApoScreen™ Annexin V Apoptosis Assay 
An apoptosis assay was carried out using AnnexinV/PI double staining and flow 
cytometry to assess cytotoxic potential of AHR ligands (PCB126, E804, BIO, IO), 
Didox or LPS in Raw 264.7 murine macrophages. None of the cells groups 
treated with Didox, LPS or AHR ligands showed significant signs of cell death or 
apoptosis (Fig 3.1). Cells which stained positive Annexin-V/PI were generally 
less than 1% in all cases investigated. Thus, almost all treated cells excluded PI 
stain and stained negative for Annexin V. The exclusion of PI and negative 
staining of Annexin-V allowed further exploration of action these drugs knowing 
that they are not cytotoxic to Raw cells at the concentrations tested. 
 
Fluorescence Microscopy Analysis of Cell death using Hoescht/PI staining 
Hoechst 33342, a type of blue-fluorescence dye (excitation/emission maxima 
≈350/461 nm when bound to DNA), stains the condensed chromatin in apoptotic 
cells more brightly than normal chromatin. Propidium iodide (PI), a red-
fluorescence dye (excitation/emission maxima ≈535/617 nm when bound to 
DNA), is only permeant to dead cells. The staining pattern resulting from the 
simultaneous use of these dyes makes it possible to distinguish normal, 
apoptotic, and dead cell populations by fluorescence microscopy. Cells were 
treated with Didox or AHR ligands and stained with Hoechst/PI double stain. 
Fluorescent microscope images confirmed that none of the drugs induced 
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apoptosis or cell death since all Raw 264.7 cells excluded PI stain and only 












Figure 3.1. Flow cytometric analysis of Raw 264.7 cells treated with Didox, LPS 
and AHR-ligands(PCB126, E804, IO and BIO). Raw 264.7 murine macrophages were 
seeded in 24 well plates for 3hrs and treated with 10 µM of AHR ligands (PCB126, E804, 
IO), LPS (0.1 µg/ml) or Didox (100µM) for 24hrs.  Apoptosis was quantified by 
measurement of externalized phosphatidylserine residues as detected by flow cytometer 


















Figure 3.2. Hoechst/PI apoptosis evaluation of Raw 264.7 cells treated with AHR 
ligands (PCB126, E804, IO) and Didox. Cells were treated as indicated above, 
Hoescht/PI stain was added the and cells were viewed under a fluorescent microscope 
after fixing and mounting on glass slide. 50 µm 
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Evaluation of AHR nuclear translocation using Immunofluorescence 
Microscopy. 
The induction AHR ligands mediated oxidative stress in many cells occurs via 
binding to the the aryl hydrocarbon receptor (AHR) and activating the AHR 
pathway. The inactive form of the AHR molecule resides in the cytoplasm and 
upon binding to AHR ligands it translocates to the nucleus to induce targeted 
expression of responsive genes. To assess AHR nuclear translocation after 
binding AHR ligands (PCB126, E804, IO) in Raw 264.7 murine macrophages, 
immunofluorescence microscopy was used. All AHR ligands used were able to 
induce AHR nuclear translocation with PCB126 and E804 inducing higher levels 
of nuclear translocation as evidence by lesser AHR in cytoplasm and more 
fluorescence in the nucleus (Fig 3.3). The AHR ligands induced translocation 
was evidently suppressed by addition of Didox since lower nuclear AHR 
fluorescence was observed upon its addition. PCB104 is not an AHR ligand and 






Figure 3.3. The effect of Didox on PCB126, E804, and IO-induced AHR nuclear 
translocation in Raw 264.7 murine macrophages.  Raw 264,7 cells were treated 
with AHR ligands in the presence or absence of Didox and immunofluorescence 








Assessment of CYP1A1 induction in Raw 264.7 cells using Immuno-
fluorescence Microscopy. 
Induction of Cyp1A1 is known to represent a significant event in the toxicity of 
AHR ligands and the Cyp1A1 gene provides a model system for studying the 
mechanism of gene transcription by AHR. Therefore expression of Cyp1A1 after 
AHR activation is indicative of activation of the AHR pathway and further 
confirms binding of AHR ligands to AHR. To assess CYP1A1 activity in Raw 
264,7 murine macrophages after treatment with candidate AHR ligands 
(PCB126, E804, IO), immunofluorescence microscopy was used.  PCB126 and 
E804 consistently induced higher Cyp1A1 expression as evidenced by higher 
fluorescence in Raw cells after treatment (Fig 3.4 and 3.4b).  
 
IO also induced Cyp1A1 expression albeit at lower levels than PCB126 and 
E804. The expression of Cyp1A1 induced these AHR ligands was variably 
inhibited by addition of Didox and lower fluorescence was observed in the Raw 
cells when Didox was included in the regimen. PCB104 is not an AHR ligand and 









Figure 3.4. The effect of Didox on CYP1A1 induction by AHR ligands (PCB126, 
E804, and IO) in Raw 264.7 murine macrophages. Raw 264.7 cells were cultured 
cells in 6-well culture plates and treated with 10 µM of AHR ligands (PCB126, E804, IO) 
or non-AHR ligands (PCB104) with or without Didox (100µM).  CYP1A1 antibody was 
measure using FITC-labeled goat anti-rabbit IgG and nuclei were stained with DAPI. 




Figure 3.4b. Qunatitative analysis of the effect of Didox on CYP1A1 induction by 
AHR ligands (PCB126, E804, IO) in Raw 264.7 murine macrophages. Raw 264.7 
cells were cultured cells in 6-well culture plates and treated with 10 µM of AHR ligands 
(PCB126, E804, IO) or non-AHR ligands (PCB104) with or without Didox (100µM).  
CYP1A1 antibody was measure using FITC-labeled goat anti-rabbit IgG and nuclei were 
stained with DAPI. Slides were viewed under Nikon AZ100 Epi-Fluorescent Microscope. 
Mean fluorescence intensities were measured in various fields in triplicates and 
treatment effects were analysed using the paired t-test and p<0.05 (*) was considered to 
be statistically significant. 
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AHR and Cyp1a1 Gene expression using Real-Time PCR 
Real-time PCR using specific AHR and CYP1A1 primers was carried out to 
evaluate the effect of AHR ligands (PCB126, E804, IO) on AHR and Cyp1A1 
mRNA expression in Raw 264.7 murine macrophages. PCB126 induced the 
highest mRNA expression of more than 60-fold above the controls followed by 
E804 with a 24-fold change and IO with less than 10-fold difference (Fig 3.5). 
This AHR ligand-induced mRNA expression was significantly suppressed by 
addition of Didox. Thus, Didox inhibited mRNA expression levels of AHR and 
Cyp1A1 in Raw 264.7 murine macrophages treated with PCB126, E804 and IO. 
 
Mouse Oxidative Stress Gene Analysis using RT2 ProfilerTM PCR-Arrays.  
Once it was established that these AHR ligands (at 10 µM) do not induce cell 
death while inducing AHR and Cyp1A1 activity in Raw 264.7 cells, a search for 
oxidative stress related candidate genes was carried out using PCB126, a more 
potent AHR ligand. The Mouse Oxidative Stress RT2 ProfilerTM PCR-Arrays 
revealed that expression of several genes playing important roles in induction of 
oxidative stress in macrophages were significantly attenuated upon addition of 
PCB126 (Table 3.2). Of these, genes of the NADPH oxidase family were notably 
induced whereas most antioxidant genes such as catalase, glutathione 
peroxidases, peroxiredoxins and superoxide dismutases, were variably 
suppressed upon addition of PCB126 in Raw 264.7 cells. Addition of Didox 
suppressed PCB126-induced expression of NADPH oxidases while inducing 
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expression of antioxidant genes (Catalase, glutathione peroxidase, superoxide 





































































































































































































































































































Figure 3.5. The effect of Didox and LPS on AHR and CYP1A1 mRNA 
expression in Raw 264.7 cells (Real-time PCR study with specific primers). 
To evaluate the effect of AHR ligands (PCB126, E804, IO) on AHR and Cyp1a1 
mRNA expression, RNA was extracted and cDNA obtained from treated murine 












Table 3.2. Real-time PCR multigene Array for evaluation of mouse 
oxidative stress related genes in Raw 264. 7 cells after treatment with 
PCB126 in presence or absence of Didox. For data analysis the ∆∆Ct 
method was used; for each gene fold-changes were calculated as difference in 
gene expression between untreated controls and treated cell cultures. A 
positive value indicates gene up-regulation and a negative value indicates 
gene down-regulation. 
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Didox inhibits PCB126-induced ROS production in Raw cells 
Intracellular ROS production in Raw 264.7 cells was measured using 5-(and-6)-
chloromethyl-2',7'-dichlorodihydrofluorescein diacetate (CM-H2DCFDA) which is 
hydrolyzed to DCFH in the cell, and DCFH is oxidized to form highly fluorescent 
DCF in the presence of the correct oxidant. ROS generation was detected as a 
result of DCFH oxidation after addition of PCB126 in Raw 264.7 cells and this 
was indicated by higher fluorescence in the cells upon treatment (Fig 3.6 and 
3.6b). The resulting fluorescence was subdued by co-incubation with Didox to 








Figure 3.6. Didox inhibits ROS production in Raw 264.7 cells treated with PCB126. 
Cells were seeded at 5 x 10 5 cells/well in eight chamber cell culture slides for 3h and 
then treated with PCB126 (10 µM) in the presence or absence of Didox (100µM). 
H2DCFA solution was added at 10
-5M to all wells and incubated for an additional 30 min 
at 37˚C. The slides were viewed under the fluorescence microscope and images capture 




Figure 3.6b. Quantitative assessment of ROS production in Raw 264.7 cells 
treated with PCB126 and Didox. Cells were seeded at 5 x 10 5 cells/well in eight 
chamber cell culture slides for 3h and then treated with PCB126 (10 µM) in the presence 
or absence of Didox (100µM). H2DCFA solution was added at 10
-5M to all wells and 
incubated for an additional 30 min at 37˚C. The slides were viewed under the 
fluorescence microscope and images capture using the digital camera. Mean 
fluorescence intensities were measured in various fields in triplicates and treatment 




Assessment of intracellular superoxide radical production in Raw 264.7 
cells 
Of the ROS molecules produced by macrophages during inflammation, 
superoxides are in the most reactive catergory. DHE, a vital dye sensitive to 
superoxide oxidation, was employed to detect superoxide production in Raw cells 
after treatment with PCB126 and E804 and to determine if this production can be 
attenuated by Didox. An intense red fluorescence was observed upon treatment 
of cells with PCB126 and E804 to indicate a robust production of intracellular 
superoxide radicals in Raw 264.7 cells (Fig 3.7 and 3.7b). This robust red 
fluorescence was significantly reduced by addition of Didox in these cells.  The 
unoxidized DHE maintained a blue fluorescence in all culture treatments.  
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Figure 3.7. Didox inhibits PCB126 and E804-induced oxidative burst and 
intracellular superoxide production in Raw 264.7 cells. Cells were loaded with 10 µM 
DHE for 15min, and treated for 120 min with 10 µM of AHR ligands (PCB126 and E804) 
or non-AHR ligands (PCB104) with or without Didox (100µM). Slides were analyzed 




Figure 3.7b. Quantitative analysis of oxidative burst and intracellular superoxide 
production in Raw 264.7 cells treated Didox, PCB126 and E804. Cells were loaded 
with 10 µM DHE for 15min, and treated for 120 min with 10 µM of AHR ligands (PCB126 
and E804) with or without Didox (100µM). Slides were analyzed using the Nikon AZ100 
Epi-Fluorescent Microscope. Mean fluorescence intensities were measured in various 
fields in triplicates and treatment effects were analysed using the paired t-test and 





The aryl hydrocarbon receptor (AHR) is a ligand activated transcription factor that 
regulates genes involved in xenobiotic metabolism, cell proliferation, and 
differentiation (Meijer et al., 2007). There have been many reports about toxic 
mechanisms of AHR ligands or xenobiotics capable of activating the AHR 
pathway and they demonstrated the relationship between oxidative stress and 
the site of target organs. Certain PCBs can compromise normal functions of 
vascular endothelial cells by activating oxidative stress-sensitive signaling 
pathways and subsequent proinflammatory events critical in the pathology of 
atherosclerosis and cardiovascular disease (Henning et al., 2002). However, 
there are some reports about the protective effects of some antioxidants against 
AHR ligands in cell culture systems with vitamin E being shown to protect against 
neurotoxicity caused by Aroclor1254 or PBC-induced toxicity if zebrafish 
embryos (Na et al., 2009).  
 
Thus, it was worthwhile to investigate the ability of Didox to inhibit the AHR 
pathway in Raw 264.7 murine macrophages since it has been demonstrated to 
be a powerful antioxidant in various experimental models. Raw 264.7 murine 
macrophages were selected as a preferred model for this study since 
macrophages play an active role in oxidative stress mediated diseases and also 
express AHR along with associated molecules of the AHT pathway. Several AHR 
ligands were identified and used as candidates for use in the study, and this 
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include PCB126, E804, and IO whereas a non-AHR binding molecule, PCB104, 
was used to ensure specificity of reactions.  
 
Since AHR ligands can induce lethal toxicity in macrophages, it was important to 
first evaluate the cytotoxic profiles of these candidate ligands and their ability to 
induce apoptosis in Raw 264.7 macrophages. Using the Annexin-V/PI flow 
cytometry assay and Hoechst/PI apoptosis assay, it is clearly demonstrated here 
that none of the AHR ligands induced apoptosis in these Raw macrophages 
when used at 10 µM concentration for 24h. More than 98% of the Raw 264.7 
cells remained viable and showed no noticeable signs of apoptosis after 
treatment with PCB126, E804, or IO. Cells mostly stained negative for Annexin-V 
and excluded PI while staining positive for the cell permeant, Hoechst 33342. It 
was therefore concluded that these doses can be safely used for evaluating AHR 
pathway associated responses in these cells line for durations up to 24h without 
cell death induction.  
 
The next step was to evaluate if these candidate xenobiotics can bind to AHR 
and induce its translocation from the cytosol to the nucleus. Previous studies 
using urine of healthy individuals as a starting biological material to identify AHR 
ligands recognized indigo and indirubins as potent AHR activators. Hence, 
indirubin derivatives such as E804 and IO were evaluated for the ability to bind 
AHR in Raw 264.7 murine macrophages. PCB126 has been well demonstrated 
to strongly activate AHR pathways in various developmental model systems and 
 132 
its ability to activate AHR reactions in Raw 264.7 cells was also evaluated. 
Evaluation of AHR nuclear translocation using immunofluorescence microscopy 
showed that all the AHR ligands tested were able to induce movement of AHR 
from cytosol to the nucleus. PCB126 and E804 were shown to be more potent 
AHR activators compared to IO. Addition of Didox to these treatments resulted in 
lower AHR nuclear translocation and this indicated that Didox suppressed AHR 
activation mediated by PCB126, E804, and IO. PCB104 failed to induce nuclear 
translocation of AHR and this demonstrated the AHR binding specificity of the 
AHR ligands used. The absence of an identifiable endogenous AHR ligand has 
led to possibilities that AHR activation can be activated via association to AHR in 
ways other than direct AHR binding. To this effect, an antioxidant such as vitamin 
E has been subsequently shown to protect against gross morphological changes 
induced by PCB126 (Meijer et al., 2007). It is therefore possible that an 
antioxidant like Didox could be using related inhibitory features to suppress AHR 
binding of PCB126, E804, and IO in Raw 264.7 cells. 
 
Activation of AHR leads to enhanced expression of a variety of genes and the 
most prominent of these is cytochrome P450 (CYP1A1), playing a major role in 
generating subsequent oxidative stress responses (Knockaert et al., 2004). Since 
PCB126, E804, and IO were shown to bind AHR in Raw 264.7 cells their ability 
to induce CYP1A1 expression was assessed. Immunofluorescence microscopy 
analysis of Raw 264.7 cells treated with these AHR ligands revealed a higher 
expression of CYP1A1 in these cells compared to untreated and PCB104 treated 
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controls. A more pronounced CYP1A1 expression was noticeable in PCB126 and 
E804 treated cells compared to IO-treated samples. Interestingly, these results 
correlate positively with AHR binding studies which revealed that PCB126 and 
E804 induced higher AHR nuclear translocation in Raw 264.7 cells compared to 
those treated with IO. When Didox was added to the treatment regimen 
containing these AHR ligands, CYP1A1 expression was significantly suppressed. 
These results suggest an inhibitory role of Didox against AHR activation and 
subsequent CYP1A1 expression in Raw 264.7 murine macrophages. Gene 
expression studies using Real-time PCR revealed that Didox inhibited PCB126-, 
E804-, and IO-induced AHR and CYP1A1 mRNA expression in Raw 264.7 
macrophages. Didox might therefore be inhibiting AHR activation via suppression 
of both mRNA and protein expression of AHR and CYP1A1. 
 
AHR activation has been shown to be accompanied by high levels of oxidative 
stress and production of reactive oxygen species in various cell culture and 
animal systems. A search for oxidative stress response genes was carried out to 
identify genes that may targets for PCB126 induced activation in Raw 264.7 
murine macrophages. A mouse oxidative stress real-time PCR array was carried 
to evaluate 84 oxidative stress and cytotoxicity related genes in Raw 264.7 
murine macrophages. PCB126 strongly increased mRNA expression of NADPH 
oxidase 1 and 4, NADPH oxidase activator, NADPH organizer and Parkinson 
disease 7 gene in raw cells. NADPH oxidase of phagocytes plays a crucial role in 
host defense by generating an oxidative burst and producing reactive oxygen 
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species (ROS) that are intended to kill invading microbes (Rada et al., 2004). 
Didox addition, however, lowered PCB126-induced mRNA expression of these 
NADPH oxidase family members as indicated by lowered fold changes when 
Didox was included in the treatments. Moreover, Didox increased expression of 
genes such as catalase, glutathione peroxidase, peroxiredoxin and superoxide 
dismutase. Catalase play a central role in the decomposition of hydrogen 
peroxide and, together with glutathione peroxidases and peroxiredoxins, form the 
highly efficient machinery for detoxifying cells by reducing hydrogen peroxide 
levels. Superoxide dismutases are very efficient at reducing the levels of highly 
reactive superoxide free radical. The increase in mRNA expression of this family 
of genes by Didox suggests an important role of Didox as an antioxidant 
molecule in Raw 264.7 murine macrophages against PCB126.  
 
Due to the changes observed in profiles of antioxidant genes as effect by Didox, 
it therefore was necessary to further evaluate intracellular ROS production and 
reactive oxidative burst in Raw 264.7 after treatment with AHR ligands. ROS 
generation immunofluorescence assay using oxidation of DCFH to DCF revealed 
an increased intracellular ROS production in Raw 264.7 cells treated with 
PCB126, a more potent AHR activator. This PCB126-mediated ROS production 
was lowered by addition Didox. The reduction of PCB126-induced ROS 
production by Didox correlates with earlier RT-PCR gene expression which 
showed increased catalase expression. Hydrogen peroxide is mainly responsible 
for ROS production detected through DCFH system and since it is decomposed 
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by catalase-mediated catalysis, Didox-uprelugation of catalase gene expression 
could be mainly responsible for the observed ROS suppression in Raw 264.7 
macrophages.  
 
Assessment of superoxide radical production in Raw 264.7 murine macrophages 
treated with AHR ligands was achieved using the DHE system which is highly 
sensitive to superoxide oxidation and emits a strong red fluorescence upon 
contact. A robust red fluorescence indicative of oxidative burst and increased 
superoxide production was observed when cells were treated with PCB126 and 
E804. IO also increased superoxide production compared to untreated and 
PCB104 controls. Intracellular superoxide production was strongly reduced by 
addition Didox in all treatments of Raw macrophages with AHR ligands. These 
results were however not surprising since Didox was earlier shown to increase 
expression of superoxide dismutase, an enzyme responsible for neutralizing 











Dysfunction and aberrant activation of macrophages is a critical underlying cause 
of the initiation of cardiovascular, neurodegenerative and inflammatory diseases. 
In addition to macrophage dysfunction, another functional change in 
cardiovascular and neurodegenerative diseases is the activation of the 
endothelium that is manifested as an increase in the production of oxidative 
stress related molecules. These high levels of reactive oxygen molecules, along 
with cytokines and adhesion molecules, are proposed to mediate the 
inflammatory aspects of degenerative disease by regulating the entry of 
leukocytes, both macrophages and lymphocytes, into the vascular wall.  
 
There is evidence that the CYP1A1 subfamily is present in most and possibly all 
animal and human systems, including macrophages. For example, CYP1A1 has 
been detected in endothelial linings of fish and rodents, as well as in cultured 
human and porcine endothelial cells (Smolowitz et al., 1992; Stegeman et al., 
1995; Toborek et al., 1995; Celander et al., 1997; Zhao et al., 1998; Hennig et 
al., 1999; Annas et al., 2000; Schlezinger and Stegeman, 2001). Oxidative stress 
and increased CYP1A1 expression can be induced via There is increasing 
evidence that exposure to polycyclic aromatic hydrocarbons can lead to 
cardiovascular toxicity and atherosclerosis. For example, there was a significant 
increase in mortality from cardiovascular diseases among Swedish capacitor 
manufacturing workers exposed to PCBs for at least 5 years (Gustavsson and 
Hogstedt, 1997), and most excess deaths were due to cardiovascular disease in 
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power workers exposed to phenoxy herbicides and PCBs in waste transformer oil 
(Hay and Tarrel, 1997). 
 
The ability of Didox to downregulate AHR-mediated activation therefore presents 
an antioxidant system that can reduce AHR-mediated oxidative stress and 
cellular toxicity in macrophages. Didox has also been shown to potently inhibit 
NF-κB activation in various experimental models. Earlier work by Henning’s Lab 
indicates that coplanar PCBs that function as AhR agonists may be 
proinflammatory by activating NF-κB in vascular endothelial cells (Henning et al., 
2002) and that this resultant oxidative stress can play a critical role in observed 
PCB-mediated endothelial cell dysfunction (Hennig et al., 1996). The ability of 
Didox to inhibit NF-κB and AHR activation provides a non-steroid anti-
inflammatory drug that may be used as a potential treatment in disease 





In this study, Didox has been demonstrated to block inflammation and oxidative 
stress induced by LPS and AHR ligands in Raw 264.7 murine macrophages. 
These results present Didox as a novel therapeutic compound that may block 
oxidative stress and treat inflammation-based diseases by regulating 
macrophage activity.  The ability of Didox to inhibit oxidative stress and regulate 
macrophage activity compliments its ribonucleotide reductase inhibitory capacity. 
The multifaceted behavior of Didox arms it with numerous target point in treating 
ailments exacerbated by deregulated macrophage activation. This is because 
macrophages undergo a wide spectrum of polarized activation states and have 
the dual potential to elicit tissue destructive reactions and to promote tumor 
progression. In general, tumor-associated macrophages from established tumors 
and the related myeloid-derived suppressor cells help cancer progression and 
metastasis. Therefore, these types of destructive macrophages are a key 
component of pathways connecting inflammation and cancer. Didox has the 
ability to inhibit cancer growth due to its ribonucleotide reductase inhibitory 
potential and by demonstrating its ability to inhibit inflammation or suppress 
oxidative stress presents it with two important target points: cell division and 
inflammation. 
 
In this study Didox has been demonstrated to inhibit production of TNF-α, Cox-2, 
NO, ROS, and IL-6. TNF-α and IL-6 are two of the major inflammatory cytokines 
targeted for therapeutic treatment of inflammation based disease conditions and 
the ability of Didox to suppress their production is of paramount importance. Cox-
2 is an enzyme that mediates production of prostaglandins responsible for 
inflammation and pain. Cox-2 inhibitors have been sought after for decades to 
alleviate inflammation and pain caused by high Cox-2 expression. By exhibiting 
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Cox-2 inhibitory abilities, Didox provides a promising NSAID that can be used to 
block inflammation and pain associated with high levels of Cox-2. The most 
important aspect of Didox is its ability to upregulate gene expression of 
antioxidants such catalase, thioredoxins, superoxide dismutase, and glutathione 
peroxidase. This upregulation of antioxidants is most probably responsible for the 
reduction in ROS production observe upon treatment of LPS- or AHR-induced 
Raw 264.7 cells with Didox. NF-κB and AHR can be activated by presence of 
high reactive oxygen intermediates. Thus, the suppression of ROS production by 
Didox may be responsible for its inhibitory effect on NF-κB or AHR. NF-κB and 
AHR are redox sensors and by depleting the cellular ROS pool Didox might be 
indirectly suppressing NF-κB and AHR activation along with associated 
cytotoxicities. Further studies can be designed to determine if Didox directly 
binds NF-κB and AHR or whether their inhibition is through indirect association. 
Using an appropriate inflammation model system animal studies can be carried 
to determine if the inflammation and oxidative stress inhibitory potential of Didox 
shown in Raw 264.7 murine macrophages can be sustained in an in vivo system 
and to further determine if this drug carries other physiologically rewarding 
properties.  
 
Chronic inflammation caused by aberrant macrophage activation and 
environmental contaminants such as those that activate the AHR pathway or NF-
κB pathway play a pivotal role in pathogenesis of most diseases. Administered 
alone or in combination with other drugs that inhibit similar pathways, Didox 
provides a more effective candidate which can regulate oxidative stress and 
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